Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	tyrosine-ester sulfotransferase activity	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.38e-11	4	40	4	GO:0017067
GeneOntologyMolecularFunction	amine sulfotransferase activity	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.38e-11	4	40	4	GO:0047685
GeneOntologyMolecularFunction	flavonol 3-sulfotransferase activity	SULT1A2 SULT1A4 SULT1A1 SULT1A3	6.89e-11	5	40	4	GO:0047894
GeneOntologyMolecularFunction	steroid sulfotransferase activity	SULT1A2 SULT1A4 SULT1A1 SULT1A3	4.81e-10	7	40	4	GO:0050294
GeneOntologyMolecularFunction	sulfate binding	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.73e-09	9	40	4	GO:0043199
GeneOntologyMolecularFunction	aryl sulfotransferase activity	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.87e-09	10	40	4	GO:0004062
GeneOntologyMolecularFunction	3'-phosphoadenosine 5'-phosphosulfate binding	SULT1A2 SULT1A4 SULT1A1 SULT1A3	9.74e-09	13	40	4	GO:0050656
GeneOntologyMolecularFunction	sulfotransferase activity	SULT1A2 SULT1A4 SULT1A1 SULT1A3	4.37e-06	55	40	4	GO:0008146
GeneOntologyMolecularFunction	oncostatin-M receptor activity	LIFR OSMR	1.17e-05	3	40	2	GO:0004924
GeneOntologyMolecularFunction	transferase activity, transferring sulphur-containing groups	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.44e-05	74	40	4	GO:0016782
GeneOntologyMolecularFunction	ciliary neurotrophic factor receptor binding	LIFR OSMR	8.16e-05	7	40	2	GO:0005127
GeneOntologyMolecularFunction	quaternary ammonium group binding	CHRNA4 CHRNB2 SCARB2	1.06e-04	46	40	3	GO:0050997
GeneOntologyMolecularFunction	acetylcholine binding	CHRNA4 CHRNB2	3.01e-04	13	40	2	GO:0042166
GeneOntologyMolecularFunction	sulfur compound binding	SULT1A2 SULT1A4 SULT1A1 SULT1A3 LPL	4.44e-04	323	40	5	GO:1901681
GeneOntologyMolecularFunction	acetylcholine-gated monoatomic cation-selective channel activity	CHRNA4 CHRNB2	5.22e-04	17	40	2	GO:0022848
GeneOntologyMolecularFunction	apolipoprotein binding	LRP4 LPL	7.27e-04	20	40	2	GO:0034185
GeneOntologyMolecularFunction	acetylcholine receptor activity	CHRNA4 CHRNB2	9.64e-04	23	40	2	GO:0015464
GeneOntologyMolecularFunction	excitatory extracellular ligand-gated monoatomic ion channel activity	CHRNA4 CHRNB2	3.35e-03	43	40	2	GO:0005231
GeneOntologyMolecularFunction	GTPase binding	DOCK2 ARHGDIB BNIP3 FGD3	5.69e-03	360	40	4	GO:0051020
GeneOntologyMolecularFunction	transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential	CHRNA4 CHRNB2	5.82e-03	57	40	2	GO:1904315
GeneOntologyMolecularFunction	neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential	CHRNA4 CHRNB2	6.44e-03	60	40	2	GO:0099529
GeneOntologyBiologicalProcess	4-nitrophenol metabolic process	SULT1A2 SULT1A4 SULT1A1 SULT1A3	6.05e-11	5	40	4	GO:0018960
GeneOntologyBiologicalProcess	purine ribonucleoside bisphosphate metabolic process	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.83e-08	17	40	4	GO:0034035
GeneOntologyBiologicalProcess	3'-phosphoadenosine 5'-phosphosulfate metabolic process	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.83e-08	17	40	4	GO:0050427
GeneOntologyBiologicalProcess	ethanol catabolic process	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.83e-08	17	40	4	GO:0006068
GeneOntologyBiologicalProcess	ethanol metabolic process	SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.64e-08	18	40	4	GO:0006067
GeneOntologyBiologicalProcess	primary alcohol catabolic process	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.05e-07	23	40	4	GO:0034310
GeneOntologyBiologicalProcess	sulfation	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.06e-07	27	40	4	GO:0051923
GeneOntologyBiologicalProcess	catechol-containing compound metabolic process	SULT1A2 SULT1A4 SULT1A1 SULT1A3 CHRNB2	3.09e-07	74	40	5	GO:0009712
GeneOntologyBiologicalProcess	catecholamine metabolic process	SULT1A2 SULT1A4 SULT1A1 SULT1A3 CHRNB2	3.09e-07	74	40	5	GO:0006584
GeneOntologyBiologicalProcess	primary alcohol metabolic process	SULT1A2 SULT1A4 SULT1A1 SULT1A3 CYP11B1	1.86e-06	106	40	5	GO:0034308
GeneOntologyBiologicalProcess	flavonoid metabolic process	SULT1A4 SULT1A1 SULT1A3	1.91e-06	13	40	3	GO:0009812
GeneOntologyBiologicalProcess	alcohol catabolic process	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.04e-06	47	40	4	GO:0046164
GeneOntologyBiologicalProcess	estrogen metabolic process	SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.07e-06	52	40	4	GO:0008210
GeneOntologyBiologicalProcess	biogenic amine metabolic process	SULT1A2 SULT1A4 SULT1A1 SULT1A3 CHRNB2	3.57e-06	121	40	5	GO:0006576
GeneOntologyBiologicalProcess	purine nucleoside bisphosphate metabolic process	ELOVL4 SULT1A2 SULT1A4 SULT1A1 SULT1A3	7.81e-06	142	40	5	GO:0034032
GeneOntologyBiologicalProcess	phenol-containing compound metabolic process	SULT1A2 SULT1A4 SULT1A1 SULT1A3 CHRNB2	7.81e-06	142	40	5	GO:0018958
GeneOntologyBiologicalProcess	nucleoside bisphosphate metabolic process	ELOVL4 SULT1A2 SULT1A4 SULT1A1 SULT1A3	7.81e-06	142	40	5	GO:0033865
GeneOntologyBiologicalProcess	ribonucleoside bisphosphate metabolic process	ELOVL4 SULT1A2 SULT1A4 SULT1A1 SULT1A3	7.81e-06	142	40	5	GO:0033875
GeneOntologyBiologicalProcess	amine metabolic process	SULT1A2 SULT1A4 SULT1A1 SULT1A3 CHRNB2	9.55e-06	148	40	5	GO:0009308
GeneOntologyBiologicalProcess	organic hydroxy compound catabolic process	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.20e-05	73	40	4	GO:1901616
GeneOntologyBiologicalProcess	oncostatin-M-mediated signaling pathway	LIFR OSMR	2.19e-05	4	40	2	GO:0038165
GeneOntologyBiologicalProcess	cellular response to nitrogen compound	STIM1 SULT1A4 SULT1A3 CYP11B1 CHRNA4 CHRNB2 LPL ZC3HAV1	8.21e-05	752	40	8	GO:1901699
GeneOntologyBiologicalProcess	T-tubule organization	MYOF FER1L5	1.31e-04	9	40	2	GO:0033292
GeneOntologyBiologicalProcess	acetylcholine receptor signaling pathway	STIM1 CHRNA4 CHRNB2	1.32e-04	51	40	3	GO:0095500
GeneOntologyBiologicalProcess	alcohol metabolic process	MYOF SULT1A2 SULT1A4 SULT1A1 SULT1A3 CYP11B1	1.32e-04	412	40	6	GO:0006066
GeneOntologyBiologicalProcess	cellular response to acetylcholine	STIM1 CHRNA4 CHRNB2	1.48e-04	53	40	3	GO:1905145
GeneOntologyBiologicalProcess	dopamine metabolic process	SULT1A4 SULT1A3 CHRNB2	1.48e-04	53	40	3	GO:0042417
GeneOntologyBiologicalProcess	oxoacid metabolic process	ELOVL4 SULT1A2 SULT1A4 CPT1A SULT1A1 SULT1A3 ABCC10 LPL ASNS	1.54e-04	1058	40	9	GO:0043436
GeneOntologyBiologicalProcess	xenobiotic metabolic process	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.58e-04	141	40	4	GO:0006805
GeneOntologyBiologicalProcess	organic acid metabolic process	ELOVL4 SULT1A2 SULT1A4 CPT1A SULT1A1 SULT1A3 ABCC10 LPL ASNS	1.61e-04	1064	40	9	GO:0006082
GeneOntologyBiologicalProcess	dopamine catabolic process	SULT1A4 SULT1A3	1.63e-04	10	40	2	GO:0042420
GeneOntologyBiologicalProcess	response to acetylcholine	STIM1 CHRNA4 CHRNB2	1.74e-04	56	40	3	GO:1905144
GeneOntologyBiologicalProcess	positive regulation of RIG-I signaling pathway	DDX60 ZC3HAV1	1.99e-04	11	40	2	GO:1900246
GeneOntologyBiologicalProcess	catecholamine catabolic process	SULT1A4 SULT1A3	1.99e-04	11	40	2	GO:0042424
GeneOntologyBiologicalProcess	behavioral response to nicotine	CHRNA4 CHRNB2	1.99e-04	11	40	2	GO:0035095
GeneOntologyBiologicalProcess	catechol-containing compound catabolic process	SULT1A4 SULT1A3	1.99e-04	11	40	2	GO:0019614
GeneOntologyBiologicalProcess	organic hydroxy compound metabolic process	MYOF SULT1A2 SULT1A4 SULT1A1 SULT1A3 CYP11B1 CHRNB2	2.07e-04	641	40	7	GO:1901615
GeneOntologyBiologicalProcess	hormone metabolic process	SULT1A2 SULT1A4 SULT1A1 SULT1A3 CYP11B1	2.19e-04	286	40	5	GO:0042445
GeneOntologyBiologicalProcess	response to glucocorticoid	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.56e-04	160	40	4	GO:0051384
GeneOntologyBiologicalProcess	regulation of hormone levels	STIM1 SULT1A2 SULT1A4 CPT1A SULT1A1 SULT1A3 CYP11B1	3.07e-04	684	40	7	GO:0010817
GeneOntologyBiologicalProcess	postsynaptic signal transduction	STIM1 CHRNA4 CHRNB2	3.24e-04	69	40	3	GO:0098926
GeneOntologyBiologicalProcess	phenol-containing compound catabolic process	SULT1A4 SULT1A3	3.29e-04	14	40	2	GO:0019336
GeneOntologyBiologicalProcess	response to corticosteroid	SULT1A2 SULT1A4 SULT1A1 SULT1A3	4.45e-04	185	40	4	GO:0031960
GeneOntologyBiologicalProcess	animal organ regeneration	LIFR CPT1A UPF2	4.82e-04	79	40	3	GO:0031100
GeneOntologyBiologicalProcess	response to xenobiotic stimulus	SULT1A2 SULT1A4 CPT1A SULT1A1 SULT1A3 LYST	4.86e-04	525	40	6	GO:0009410
GeneOntologyBiologicalProcess	response to hypoxia	BNIP3 CPT1A CHRNA4 TM9SF4 CHRNB2	5.38e-04	348	40	5	GO:0001666
GeneOntologyBiologicalProcess	positive regulation of Rac protein signal transduction	DOCK2 LRP4	5.50e-04	18	40	2	GO:0035022
GeneOntologyBiologicalProcess	response to nitrogen compound	STIM1 SULT1A4 CPT1A SULT1A3 CYP11B1 CHRNA4 CHRNB2 LPL ZC3HAV1	6.02e-04	1272	40	9	GO:1901698
GeneOntologyBiologicalProcess	response to decreased oxygen levels	BNIP3 CPT1A CHRNA4 TM9SF4 CHRNB2	6.60e-04	364	40	5	GO:0036293
GeneOntologyBiologicalProcess	sulfur compound metabolic process	ELOVL4 SULT1A2 SULT1A4 SULT1A1 SULT1A3	6.68e-04	365	40	5	GO:0006790
GeneOntologyBiologicalProcess	biogenic amine catabolic process	SULT1A4 SULT1A3	6.82e-04	20	40	2	GO:0042402
GeneOntologyBiologicalProcess	regulation of RIG-I signaling pathway	DDX60 ZC3HAV1	7.52e-04	21	40	2	GO:0039535
GeneOntologyBiologicalProcess	steroid metabolic process	SULT1A2 SULT1A4 SULT1A1 SULT1A3 CYP11B1	7.63e-04	376	40	5	GO:0008202
GeneOntologyBiologicalProcess	amine catabolic process	SULT1A4 SULT1A3	8.27e-04	22	40	2	GO:0009310
GeneOntologyBiologicalProcess	cellular response to xenobiotic stimulus	SULT1A2 SULT1A4 SULT1A1 SULT1A3	8.81e-04	222	40	4	GO:0071466
GeneOntologyBiologicalProcess	small molecule catabolic process	SULT1A2 SULT1A4 CPT1A SULT1A1 SULT1A3	1.26e-03	421	40	5	GO:0044282
GeneOntologyBiologicalProcess	response to oxygen levels	BNIP3 CPT1A CHRNA4 TM9SF4 CHRNB2	1.39e-03	430	40	5	GO:0070482
GeneOntologyBiologicalProcess	signal release	STIM1 MYOF CPT1A FER1L5 CHRNA4 CHRNB2	1.51e-03	653	40	6	GO:0023061
GeneOntologyBiologicalProcess	cellular response to oxygen-containing compound	STIM1 SULT1A4 BNIP3 CPT1A SULT1A3 CYP11B1 CHRNA4 CHRNB2 LPL	1.53e-03	1450	40	9	GO:1901701
GeneOntologyBiologicalProcess	RIG-I signaling pathway	DDX60 ZC3HAV1	1.54e-03	30	40	2	GO:0039529
GeneOntologyBiologicalProcess	phagocytosis	DOCK2 FER1L5 LYST TM9SF4	1.91e-03	274	40	4	GO:0006909
GeneOntologyBiologicalProcess	regulation of dopamine secretion	CHRNA4 CHRNB2	1.98e-03	34	40	2	GO:0014059
GeneOntologyBiologicalProcess	plasma membrane repair	MYOF FER1L5	1.98e-03	34	40	2	GO:0001778
GeneOntologyBiologicalProcess	regulation of Rac protein signal transduction	DOCK2 LRP4	2.10e-03	35	40	2	GO:0035020
GeneOntologyCellularComponent	plasma membrane raft	STIM1 LRP4 MYOF CHRNB2	1.76e-04	147	40	4	GO:0044853
GeneOntologyCellularComponent	acetylcholine-gated channel complex	CHRNA4 CHRNB2	5.36e-04	18	40	2	GO:0005892
GeneOntologyCellularComponent	cholinergic synapse	CHRNA4 CHRNB2	8.05e-04	22	40	2	GO:0098981
GeneOntologyCellularComponent	dopaminergic synapse	CHRNA4 CHRNB2	8.05e-04	22	40	2	GO:0098691
MousePheno	enlarged gallbladder	SULT1A2 SULT1A4 SULT1A1 SULT1A3	8.13e-07	28	37	4	MP:0009342
MousePheno	abnormal gallbladder size	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.42e-06	32	37	4	MP:0020134
MousePheno	abnormal gallbladder morphology	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.82e-05	60	37	4	MP:0005084
MousePheno	abnormal behavioral response to nicotine	CHRNA4 CHRNB2	2.04e-05	3	37	2	MP:0020160
MousePheno	abnormal nicotine-mediated receptor currents	CHRNA4 CHRNB2	4.08e-05	4	37	2	MP:0009475
MousePheno	abnormal mammary gland morphology	LRP4 SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.75e-04	201	37	5	MP:0000627
MousePheno	abnormal apocrine gland morphology	LRP4 SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.75e-04	201	37	5	MP:0013554
MousePheno	abnormal ureter smooth muscle morphology	LIFR SCARB2	2.43e-04	9	37	2	MP:0011426
MousePheno	abnormal biliary tract morphology	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.49e-04	117	37	4	MP:0005083
MousePheno	abnormal skeletal muscle morphology	STIM1 MYOF SULT1A2 SULT1A4 SULT1A1 SULT1A3 LPL	3.20e-04	508	37	7	MP:0000759
Domain	Sulfotransferase_dom	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.01e-06	36	40	4	IPR000863
Domain	Sulfotransfer_1	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.01e-06	36	40	4	PF00685
Domain	FerA	MYOF FER1L5	1.34e-05	3	40	2	SM01200
Domain	Ferlin_A-domain	MYOF FER1L5	1.34e-05	3	40	2	IPR012560
Domain	FerA	MYOF FER1L5	1.34e-05	3	40	2	PF08165
Domain	DysFC	MYOF FER1L5	2.68e-05	4	40	2	SM00694
Domain	DysFN	MYOF FER1L5	2.68e-05	4	40	2	SM00693
Domain	Peroxin/Ferlin	MYOF FER1L5	2.68e-05	4	40	2	IPR006614
Domain	FerI	MYOF FER1L5	4.45e-05	5	40	2	SM01202
Domain	FerB	MYOF FER1L5	4.45e-05	5	40	2	SM01201
Domain	Ferlin_B-domain	MYOF FER1L5	4.45e-05	5	40	2	IPR012561
Domain	Ferlin_C	MYOF FER1L5	4.45e-05	5	40	2	PF16165
Domain	Ferlin_C	MYOF FER1L5	4.45e-05	5	40	2	IPR032362
Domain	FerIin_dom	MYOF FER1L5	4.45e-05	5	40	2	IPR012968
Domain	FerI	MYOF FER1L5	4.45e-05	5	40	2	PF08151
Domain	FerB	MYOF FER1L5	4.45e-05	5	40	2	PF08150
Domain	Hematopoietin_rcpt_Gp130_CS	LIFR OSMR	9.33e-05	7	40	2	IPR003529
Domain	HEMATOPO_REC_L_F2	LIFR OSMR	1.24e-04	8	40	2	PS01353
Domain	Nicotinic_acetylcholine_rcpt	CHRNA4 CHRNB2	5.27e-04	16	40	2	IPR002394
Domain	Acetylcholine_rcpt_TM	CHRNA4 CHRNB2	1.10e-03	23	40	2	IPR027361
Domain	-	CHRNA4 CHRNB2	1.10e-03	23	40	2	1.20.120.370
Domain	Neurotransmitter_ion_chnl_CS	CHRNA4 CHRNB2	4.18e-03	45	40	2	IPR018000
Domain	Neur_chan_memb	CHRNA4 CHRNB2	4.36e-03	46	40	2	PF02932
Domain	Neur_chan_LBD	CHRNA4 CHRNB2	4.55e-03	47	40	2	PF02931
Domain	Neur_channel	CHRNA4 CHRNB2	4.55e-03	47	40	2	IPR006201
Domain	Neur_chan_lig-bd	CHRNA4 CHRNB2	4.55e-03	47	40	2	IPR006202
Domain	NEUROTR_ION_CHANNEL	CHRNA4 CHRNB2	4.55e-03	47	40	2	PS00236
Domain	Neurotrans-gated_channel_TM	CHRNA4 CHRNB2	4.55e-03	47	40	2	IPR006029
Domain	-	CHRNA4 CHRNB2	4.55e-03	47	40	2	2.70.170.10
Pathway	KEGG_MEDICUS_ENV_FACTOR_PHIP_TO_DNA_ADDUCTS	SULT1A2 SULT1A4 SULT1A1 SULT1A3	9.55e-11	5	31	4	M47807
Pathway	KEGG_SULFUR_METABOLISM	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.35e-08	13	31	4	M18256
Pathway	WP_RETINOL_METABOLISM	SULT1A2 SULT1A4 SULT1A1 SULT1A3 LPL	3.75e-08	44	31	5	MM15851
Pathway	WP_ESTROGEN_METABOLISM	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.36e-07	22	31	4	MM15888
Pathway	REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.65e-07	23	31	4	MM14597
Pathway	REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.97e-07	24	31	4	M16289
Pathway	REACTOME_PARACETAMOL_ADME	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.49e-06	39	31	4	MM15695
Pathway	WP_SULFATION_BIOTRANSFORMATION_REACTION	SULT1A2 SULT1A4 SULT1A1	6.41e-06	17	31	3	M39483
Pathway	WP_METAPATHWAY_BIOTRANSFORMATION	SULT1A2 SULT1A4 SULT1A1 SULT1A3 CYP11B1	1.91e-05	153	31	5	MM15844
Pathway	REACTOME_PARACETAMOL_ADME	SULT1A4 SULT1A1 SULT1A3	3.38e-05	29	31	3	M45015
Pathway	KEGG_MEDICUS_ENV_FACTOR_NICOTINE_TO_JAK_STAT_SIGNALING_PATHWAY	CHRNA4 CHRNB2	4.66e-05	5	31	2	M48978
Pathway	WP_ARYLAMINE_METABOLISM	SULT1A2 SULT1A1	6.98e-05	6	31	2	M39437
Pathway	REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS	SULT1A2 SULT1A4 SULT1A1 SULT1A3	8.43e-05	107	31	4	MM14595
Pathway	REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS	SULT1A2 SULT1A4 SULT1A1 SULT1A3	9.06e-05	109	31	4	M18788
Pathway	REACTOME_HIGHLY_SODIUM_PERMEABLE_POSTSYNAPTIC_ACETYLCHOLINE_NICOTINIC_RECEPTORS	CHRNA4 CHRNB2	9.76e-05	7	31	2	M27596
Pathway	REACTOME_HIGHLY_SODIUM_PERMEABLE_POSTSYNAPTIC_ACETYLCHOLINE_NICOTINIC_RECEPTORS	CHRNA4 CHRNB2	9.76e-05	7	31	2	MM15311
Pathway	REACTOME_BIOLOGICAL_OXIDATIONS	SULT1A2 SULT1A4 SULT1A1 SULT1A3 CYP11B1	1.06e-04	219	31	5	MM14838
Pathway	REACTOME_BIOLOGICAL_OXIDATIONS	SULT1A2 SULT1A4 SULT1A1 SULT1A3 CYP11B1	1.08e-04	220	31	5	M10320
Pathway	REACTOME_DRUG_ADME	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.27e-04	119	31	4	MM15692
Pathway	REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS	CHRNA4 CHRNB2	1.67e-04	9	31	2	M27597
Pathway	REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS	CHRNA4 CHRNB2	1.67e-04	9	31	2	MM15313
Pathway	REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS	CHRNA4 CHRNB2	2.54e-04	11	31	2	M883
Pathway	REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS	CHRNA4 CHRNB2	3.05e-04	12	31	2	M48008
Pathway	REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS	CHRNA4 CHRNB2	3.05e-04	12	31	2	MM15312
Pathway	REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS	CHRNA4 CHRNB2	4.19e-04	14	31	2	M757
Pathway	REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS	CHRNA4 CHRNB2	4.83e-04	15	31	2	MM14704
Pathway	REACTOME_IL_6_TYPE_CYTOKINE_RECEPTOR_LIGAND_INTERACTIONS	LIFR OSMR	5.51e-04	16	31	2	MM15323
Pathway	REACTOME_IL_6_TYPE_CYTOKINE_RECEPTOR_LIGAND_INTERACTIONS	LIFR OSMR	6.24e-04	17	31	2	M27612
Pathway	WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II	SULT1A2 SULT1A4 SULT1A1 CYP11B1	6.57e-04	183	31	4	M39588
Pathway	KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_RAS_ERK_SIGNALING_PATHWAY	CHRNA4 CHRNB2	7.82e-04	19	31	2	M47793
Pathway	WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS	CHRNA4 CHRNB2	9.58e-04	21	31	2	M39343
Pathway	REACTOME_INTERLEUKIN_6_FAMILY_SIGNALING	LIFR OSMR	1.05e-03	22	31	2	MM15319
Pathway	REACTOME_INTERLEUKIN_6_FAMILY_SIGNALING	LIFR OSMR	1.25e-03	24	31	2	M27604
Pathway	KEGG_MEDICUS_REFERENCE_IL6_FAMILY_TO_JAK_STAT_SIGNALING_PATHWAY	LIFR OSMR	1.59e-03	27	31	2	M47906
Pathway	REACTOME_DRUG_ADME	SULT1A4 SULT1A1 SULT1A3	1.73e-03	109	31	3	M45012
Pathway	WP_FATTY_ACID_BETAOXIDATION	CPT1A LPL	2.51e-03	34	31	2	M39596
Pathway	WP_FATTY_ACID_BETAOXIDATION	CPT1A LPL	2.51e-03	34	31	2	MM15937
Pathway	WP_VITAMIN_A_AND_CAROTENOID_METABOLISM	SULT1A1 LPL	4.00e-03	43	31	2	M39554
Pubmed	Steroid sulfotransferases.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.50e-12	4	40	4	8943792
Pubmed	Mapping of the phenol sulfotransferase gene (STP) to human chromosome 16p12.1-p11.2 and to mouse chromosome 7.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.50e-12	4	40	4	8288252
Pubmed	A single mutation converts the nucleotide specificity of phenol sulfotransferase from PAP to AMP.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.50e-12	4	40	4	12390022
Pubmed	Formation of hepatic DNA adducts by methyleugenol in mouse models: drastic decrease by Sult1a1 knockout and strong increase by transgenic human SULT1A1/2.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.50e-12	4	40	4	24318996
Pubmed	Molecular cloning of cDNA encoding the phenol/aryl form of sulfotransferase (mSTp1) from mouse liver.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.50e-12	4	40	4	8424956
Pubmed	Bioactivation of food genotoxicants 5-hydroxymethylfurfural and furfuryl alcohol by sulfotransferases from human, mouse and rat: a comparative study.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.50e-12	4	40	4	25370010
Pubmed	Decreased phenol sulfotransferase activities associated with hyperserotonemia in autism spectrum disorders.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.50e-12	4	40	4	33414449
Pubmed	Identification of a new subfamily of sulphotransferases: cloning and characterization of canine SULT1D1.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	7.49e-12	5	40	4	11389699
Pubmed	Hemoglobin adducts of furfuryl alcohol in genetically modified mouse models: Role of endogenous sulfotransferases 1a1 and 1d1 and transgenic human sulfotransferases 1A1/1A2.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	7.49e-12	5	40	4	29908303
Pubmed	Determination of sulfotransferase forms involved in the metabolic activation of the genotoxicant 1-hydroxymethylpyrene using bacterially expressed enzymes and genetically modified mouse models.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	7.49e-12	5	40	4	24802129
Pubmed	The effect of knockout of sulfotransferases 1a1 and 1d1 and of transgenic human sulfotransferases 1A1/1A2 on the formation of DNA adducts from furfuryl alcohol in mouse models.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	7.49e-12	5	40	4	25053625
Pubmed	The mouse Plk gene: structural characterization, chromosomal localization and identification of a processed Plk pseudogene.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	5.23e-11	7	40	4	9370299
Pubmed	Chromosomal localization of three vacuolar-H+ -ATPase 16 kDa subunit (ATP6V0C) genes in the murine genome.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	5.23e-11	7	40	4	12438748
Pubmed	Alternative splicing, gene localization, and binding of SH2-B to the insulin receptor kinase domain.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.05e-10	8	40	4	10594240
Pubmed	The gene encoding the heart/muscle isoform of cytochrome c oxidase subunit VIII maps to mouse chromosome 7.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.88e-10	9	40	4	9166597
Pubmed	Chromosomal localization of the mouse genes encoding the ERK1 and ERK2 isoforms of MAP kinases.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.88e-10	9	40	4	9060415
Pubmed	Msx3: a novel murine homologue of the Drosophila msh homeobox gene restricted to the dorsal embryonic central nervous system.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.88e-10	9	40	4	8887328
Pubmed	Structure of the human gene (COX6A2) for the heart/muscle isoform of cytochrome c oxidase subunit VIa and its chromosomal location in humans, mice, and cattle.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.88e-10	9	40	4	9177785
Pubmed	Ethanol sulfation by the human cytosolic sulfotransferases: a systematic analysis.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.88e-10	9	40	4	23207770
Pubmed	Molecular characterization and mapping of murine genes encoding three members of the stefin family of cysteine proteinase inhibitors.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.88e-10	9	40	4	8468045
Pubmed	Inhibitory effects of kynurenic acid, a tryptophan metabolite, and its derivatives on cytosolic sulfotransferases.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.88e-10	9	40	4	19548878
Pubmed	Rat phenol-preferring sulfotransferase genes (Stp and Stp2): localization to mouse chromosomes 7 and 17.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.13e-10	10	40	4	7601475
Pubmed	Localization of the murine cholecystokinin A and B receptor genes.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	4.92e-10	11	40	4	7613026
Pubmed	Sulfotransferases in the bioactivation of xenobiotics.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	4.92e-10	11	40	4	11154739
Pubmed	Sulfation and sulfotransferases 1: Sulfotransferase molecular biology: cDNAs and genes.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	4.92e-10	11	40	4	9034160
Pubmed	Sulfotransferases: genetics and role in toxicology.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	4.92e-10	11	40	4	10720750
Pubmed	Tbx6, a mouse T-Box gene implicated in paraxial mesoderm formation at gastrulation.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	4.92e-10	11	40	4	8954725
Pubmed	Identification of four chromosomal loci determining obesity in a multifactorial mouse model.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	7.37e-10	12	40	4	7706460
Pubmed	PHR1 encodes an abundant, pleckstrin homology domain-containing integral membrane protein in the photoreceptor outer segments.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.06e-09	13	40	4	10585447
Pubmed	Structural and chemical profiling of the human cytosolic sulfotransferases.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.06e-09	13	40	4	17425406
Pubmed	Genomic organization and DNA sequences of two human phenol sulfotransferase genes (STP1 and STP2) on the short arm of chromosome 16.	SULT1A2 SULT1A1 SULT1A3	1.41e-09	3	40	3	8912648
Pubmed	Identification of two human brain aryl sulfotransferase cDNAs.	SULT1A4 SULT1A1 SULT1A3	1.41e-09	3	40	3	8363592
Pubmed	A single amino acid, glu146, governs the substrate specificity of a human dopamine sulfotransferase, SULT1A3.	SULT1A4 SULT1A1 SULT1A3	1.41e-09	3	40	3	9855620
Pubmed	cDNA sequence of a growth factor-inducible immediate early gene and characterization of its encoded protein.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.03e-09	15	40	4	1741163
Pubmed	Phase II metabolism of hesperetin by individual UDP-glucuronosyltransferases and sulfotransferases and rat and human tissue samples.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	4.54e-09	18	40	4	20056724
Pubmed	Interaction of the Brain-Selective Sulfotransferase SULT4A1 with Other Cytosolic Sulfotransferases: Effects on Protein Expression and Function.	SULT1A4 SULT1A1 SULT1A3	5.63e-09	4	40	3	32152050
Pubmed	Inactivation of Wt1 causes pre-granulosa cell to steroidogenic cell transformation and defect of ovary development†.	SULT1A2 SULT1A4 SULT1A1 SULT1A3	8.85e-09	21	40	4	32301970
Pubmed	Human cytosolic sulphotransferases: genetics, characteristics, toxicological aspects.	SULT1A2 SULT1A1 SULT1A3	1.68e-07	10	40	3	11535246
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	STIM1 LRP4 LIFR MYOF OSMR CPT1A TM9SF4 SCARB2 LPL SEL1L3	7.66e-07	1201	40	10	35696571
Pubmed	Association of the neuronal nicotinic receptor beta2 subunit gene (CHRNB2) with subjective responses to alcohol and nicotine.	CHRNA4 CHRNB2	1.29e-06	2	40	2	17226798
Pubmed	Reduced antinociception in mice lacking neuronal nicotinic receptor subunits.	CHRNA4 CHRNB2	1.29e-06	2	40	2	10235262
Pubmed	Crystal structures of SULT1A2 and SULT1A1 *3: insights into the substrate inhibition and the role of Tyr149 in SULT1A2.	SULT1A2 SULT1A1	1.29e-06	2	40	2	20417180
Pubmed	Evaluation of the Nicotinic Acetylcholine Receptor-Associated Proteome at Baseline and Following Nicotine Exposure in Human and Mouse Cortex.	CHRNA4 CHRNB2	1.29e-06	2	40	2	27559543
Pubmed	X-ray structure of the human α4β2 nicotinic receptor.	CHRNA4 CHRNB2	1.29e-06	2	40	2	27698419
Pubmed	Treatment for tobacco dependence: effect on brain nicotinic acetylcholine receptor density.	CHRNA4 CHRNB2	1.29e-06	2	40	2	23429692
Pubmed	[(3)H]Epibatidine photolabels non-equivalent amino acids in the agonist binding site of Torpedo and alpha4beta2 nicotinic acetylcholine receptors.	CHRNA4 CHRNB2	1.29e-06	2	40	2	19620239
Pubmed	Extracellular domain nicotinic acetylcholine receptors formed by alpha4 and beta2 subunits.	CHRNA4 CHRNB2	1.29e-06	2	40	2	16174636
Pubmed	Active site mutations and substrate inhibition in human sulfotransferase 1A1 and 1A3.	SULT1A1 SULT1A3	1.29e-06	2	40	2	14871892
Pubmed	Properties of mutated murine alpha4beta2 nicotinic receptors linked to partial epilepsy.	CHRNA4 CHRNB2	1.29e-06	2	40	2	18321647
Pubmed	Brain nicotinic acetylcholine receptor availability and response to smoking cessation treatment: a randomized trial.	CHRNA4 CHRNB2	1.29e-06	2	40	2	24850280
Pubmed	Genetic association analysis of tagging SNPs in alpha4 and beta2 subunits of neuronal nicotinic acetylcholine receptor genes (CHRNA4 and CHRNB2) with schizophrenia in the Japanese population.	CHRNA4 CHRNB2	1.29e-06	2	40	2	18762859
Pubmed	Galantamine is an allosterically potentiating ligand of the human alpha4/beta2 nAChR.	CHRNA4 CHRNB2	1.29e-06	2	40	2	11261808
Pubmed	Chemistry, pharmacology, and behavioral studies identify chiral cyclopropanes as selective α4β2-nicotinic acetylcholine receptor partial agonists exhibiting an antidepressant profile. Part II.	CHRNA4 CHRNB2	1.29e-06	2	40	2	23734673
Pubmed	Manipulating midbrain dopamine neurons and reward-related behaviors with light-controllable nicotinic acetylcholine receptors.	CHRNA4 CHRNB2	1.29e-06	2	40	2	30176987
Pubmed	Structural principles of distinct assemblies of the human α4β2 nicotinic receptor.	CHRNA4 CHRNB2	1.29e-06	2	40	2	29720657
Pubmed	Phenotypic comparison of two Scottish families with mutations in different genes causing autosomal dominant nocturnal frontal lobe epilepsy.	CHRNA4 CHRNB2	1.29e-06	2	40	2	12681012
Pubmed	The mouse Chrna4 A529T polymorphism alters the ratio of high to low affinity alpha 4 beta 2 nAChRs.	CHRNA4 CHRNB2	1.29e-06	2	40	2	12871652
Pubmed	Association between functional genetic polymorphisms of human sulfotransferases 1A1 and 1A2.	SULT1A2 SULT1A1	1.29e-06	2	40	2	10762004
Pubmed	Exocytic trafficking is required for nicotine-induced up-regulation of alpha 4 beta 2 nicotinic acetylcholine receptors.	CHRNA4 CHRNB2	1.29e-06	2	40	2	15741168
Pubmed	Expression of water-soluble, ligand-binding concatameric extracellular domains of the human neuronal nicotinic receptor alpha4 and beta2 subunits in the yeast Pichia pastoris: glycosylation is not required for ligand binding.	CHRNA4 CHRNB2	1.29e-06	2	40	2	21252231
Pubmed	NMR resolved multiple anesthetic binding sites in the TM domains of the α4β2 nAChR.	CHRNA4 CHRNB2	1.29e-06	2	40	2	23000369
Pubmed	Human liver thermolabile phenol sulfotransferase: cDNA cloning, expression and characterization.	SULT1A4 SULT1A3	1.29e-06	2	40	2	8117269
Pubmed	Nicotine upregulates its own receptors through enhanced intracellular maturation.	CHRNA4 CHRNB2	1.29e-06	2	40	2	15944128
Pubmed	Functional characterization of mouse alpha4beta2 nicotinic acetylcholine receptors stably expressed in HEK293T cells.	CHRNA4 CHRNB2	1.29e-06	2	40	2	15569257
Pubmed	α4β2 nicotinic acetylcholine receptors intrinsically influence body weight in mice.	CHRNA4 CHRNB2	1.29e-06	2	40	2	31881170
Pubmed	An Accessory Agonist Binding Site Promotes Activation of α4β2* Nicotinic Acetylcholine Receptors.	CHRNA4 CHRNB2	1.29e-06	2	40	2	25869137
Pubmed	Localisation of aryl sulfotransferase expression in human tissues using hybridisation histochemistry and immunohistochemistry.	SULT1A2 SULT1A1	1.29e-06	2	40	2	9566757
Pubmed	Unraveling amino acid residues critical for allosteric potentiation of (α4)3(β2)2-type nicotinic acetylcholine receptor responses.	CHRNA4 CHRNB2	1.29e-06	2	40	2	28446611
Pubmed	The fifth subunit of the (α4β2)2 β2 nicotinic ACh receptor modulates maximal ACh responses.	CHRNA4 CHRNB2	1.29e-06	2	40	2	28600847
Pubmed	Cyclic AMP-dependent protein kinase A and protein kinase C phosphorylate alpha4beta2 nicotinic receptor subunits at distinct stages of receptor formation and maturation.	CHRNA4 CHRNB2	1.29e-06	2	40	2	19101612
Pubmed	Inhibited Expression of α4β2 Nicotinic Acetylcholine Receptor in Blood Leukocytes of Chinese Patients with Vascular Dementia and in Blood Leukocytes as Well as the Hippocampus of Brain from Ischemic Rats.	CHRNA4 CHRNB2	1.29e-06	2	40	2	26858154
Pubmed	Single nucleotide polymorphisms in SULT1A1 and SULT1A2 in a Korean population.	SULT1A2 SULT1A1	1.29e-06	2	40	2	23358261
Pubmed	Identification of the Initial Steps in Signal Transduction in the α4β2 Nicotinic Receptor: Insights from Equilibrium and Nonequilibrium Simulations.	CHRNA4 CHRNB2	1.29e-06	2	40	2	31130483
Pubmed	α4β2∗ nicotinic receptors stimulate GABA release onto fast-spiking cells in layer V of mouse prefrontal (Fr2) cortex.	CHRNA4 CHRNB2	1.29e-06	2	40	2	27793780
Pubmed	[Molecular and genetic basis of idiopathic nocturnal frontal lobe epilepsy].	CHRNA4 CHRNB2	1.29e-06	2	40	2	12185808
Pubmed	Contribution of α4β2 nAChR in nicotine-induced intracellular calcium response and excitability of MSDB neurons.	CHRNA4 CHRNB2	1.29e-06	2	40	2	25451094
Pubmed	Chronic sazetidine-A maintains anxiolytic effects and slower weight gain following chronic nicotine without maintaining increased density of nicotinic receptors in rodent brain.	CHRNA4 CHRNB2	1.29e-06	2	40	2	24422997
Pubmed	Functional characterization of two human sulphotransferase cDNAs that encode monoamine- and phenol-sulphating forms of phenol sulphotransferase: substrate kinetics, thermal-stability and inhibitor-sensitivity studies.	SULT1A1 SULT1A3	1.29e-06	2	40	2	8093002
Pubmed	Thalamic nicotinic receptors implicated in disturbed consciousness in dementia with Lewy bodies.	CHRNA4 CHRNB2	1.29e-06	2	40	2	16023355
Pubmed	Association of idiopathic generalized epilepsy with polymorphisms in the neuronal nicotinic acetylcholine receptor subunits.	CHRNA4 CHRNB2	1.29e-06	2	40	2	17385675
Pubmed	A common haplotype of the nicotine acetylcholine receptor alpha 4 subunit gene is associated with vulnerability to nicotine addiction in men.	CHRNA4 CHRNB2	1.29e-06	2	40	2	15154117
Pubmed	Tonic nicotinic modulation of serotoninergic transmission in the spinal cord.	CHRNA4 CHRNB2	1.29e-06	2	40	2	11226321
Pubmed	Association of alpha4beta2 nicotinic receptor and heavy smoking in schizophrenia.	CHRNA4 CHRNB2	1.29e-06	2	40	2	18043764
Pubmed	A portable site: a binding element for 17β-estradiol can be placed on any subunit of a nicotinic α4β2 receptor.	CHRNA4 CHRNB2	1.29e-06	2	40	2	21451042
Pubmed	Role of Conformational Dynamics of Sulfotransferases SULT1A1 and SULT1A3 in Substrate Specificity.	SULT1A1 SULT1A3	1.29e-06	2	40	2	38069221
Pubmed	Requirement of the nicotinic acetylcholine receptor beta 2 subunit for the anatomical and functional development of the visual system.	CHRNA4 CHRNB2	1.29e-06	2	40	2	11344259
Pubmed	Structural and functional studies of the modulator NS9283 reveal agonist-like mechanism of action at α4β2 nicotinic acetylcholine receptors.	CHRNA4 CHRNB2	1.29e-06	2	40	2	24982426
Pubmed	The neuronal nicotinic alpha4beta2 receptor has a high maximal probability of being open.	CHRNA4 CHRNB2	1.29e-06	2	40	2	20649589
Pubmed	Sulfation pharmacogenetics: SULT1A1 and SULT1A2 allele frequencies in Caucasian, Chinese and African-American subjects.	SULT1A2 SULT1A1	1.29e-06	2	40	2	11207031
Pubmed	High-affinity α4β2 nicotinic receptors mediate the impairing effects of acute nicotine on contextual fear extinction.	CHRNA4 CHRNB2	1.29e-06	2	40	2	26688111
Pubmed	Differential roles of human monoamine (M)-form and simple phenol (P)-form phenol sulfotransferases in drug metabolism.	SULT1A1 SULT1A3	1.29e-06	2	40	2	12761191
Pubmed	Genetic polymorphisms of sulfotransferases (SULT1A1 and SULT1A2) in a Turkish population.	SULT1A2 SULT1A1	1.29e-06	2	40	2	20936502
Pubmed	The relationship among the polymorphisms of SULT1A1, 1A2 and different types of cancers in Taiwanese.	SULT1A2 SULT1A1	1.29e-06	2	40	2	12469224
Pubmed	Variants in CHRNB2 and CHRNA4 Identified in Patients with Insular Epilepsy.	CHRNA4 CHRNB2	1.29e-06	2	40	2	32536355
Pubmed	Impact of SULT1A3/SULT1A4 genetic polymorphisms on the sulfation of phenylephrine and salbutamol by human SULT1A3 allozymes.	SULT1A4 SULT1A3	1.29e-06	2	40	2	31145702
Pubmed	Differential α4(+)/(-)β2 Agonist-binding Site Contributions to α4β2 Nicotinic Acetylcholine Receptor Function within and between Isoforms.	CHRNA4 CHRNB2	1.29e-06	2	40	2	26644472
Pubmed	Nicotine acts as a pharmacological chaperone to up-regulate human alpha4beta2 acetylcholine receptors.	CHRNA4 CHRNB2	1.29e-06	2	40	2	16183856
Pubmed	Molecular basis of reactive oxygen species-induced inactivation of α4β2 nicotinic acetylcholine receptors.	CHRNA4 CHRNB2	1.29e-06	2	40	2	27445102
Pubmed	The E Loop of the Transmitter Binding Site Is a Key Determinant of the Modulatory Effects of Physostigmine on Neuronal Nicotinic α4β2 Receptors.	CHRNA4 CHRNB2	1.29e-06	2	40	2	27895161
Pubmed	Sulfation of "estrogenic" alkylphenols and 17beta-estradiol by human platelet phenol sulfotransferases.	SULT1A2 SULT1A3	1.29e-06	2	40	2	10617600
Interaction	SULT1C2 interactions	SULT1A2 SULT1A4 SULT1A1 SULT1A3	5.05e-08	19	40	4	int:SULT1C2
Interaction	SULT1A3 interactions	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.37e-07	24	40	4	int:SULT1A3
Interaction	SULT1A4 interactions	SULT1A4 SULT1A1 SULT1A3	2.60e-06	14	40	3	int:SULT1A4
Interaction	SULT1A2 interactions	SULT1A2 SULT1A1 SULT1A3	6.87e-06	19	40	3	int:SULT1A2
Interaction	SULT1A1 interactions	SULT1A2 SULT1A4 SULT1A1 SULT1A3	9.32e-06	67	40	4	int:SULT1A1
Interaction	SULT4A1 interactions	SULT1A2 SULT1A1 SULT1A3	1.42e-05	24	40	3	int:SULT4A1
Interaction	ABCC10 interactions	CHRNA4 ABCC10 CHRNB2	4.94e-05	36	40	3	int:ABCC10
Interaction	SULT1B1 interactions	SULT1A4 SULT1A3	1.07e-04	8	40	2	int:SULT1B1
Interaction	RHOC interactions	STIM1 ARHGDIB MYOF OSMR CPT1A SULT1A1 ZC3HAV1	1.34e-04	584	40	7	int:RHOC
Interaction	SCGB1D1 interactions	LIFR FCGRT SCARB2 SEL1L3	1.38e-04	133	40	4	int:SCGB1D1
Cytoband	Ensembl 112 genes in cytogenetic band chr16p11	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.01e-04	278	40	4	chr16p11
Cytoband	16p12.1	SULT1A2 SULT1A1	2.19e-04	25	40	2	16p12.1
Cytoband	Ensembl 112 genes in cytogenetic band chr5p13	LIFR OSMR	6.58e-03	139	40	2	chr5p13
GeneFamily	Sulfotransferases, cytosolic	SULT1A2 SULT1A4 SULT1A1 SULT1A3	7.99e-09	14	32	4	762
GeneFamily	Ferlin family	MYOF FER1L5	4.53e-05	6	32	2	828
GeneFamily	Cholinergic receptors nicotinic subunits	CHRNA4 CHRNB2	3.59e-04	16	32	2	173
Coexpression	VERNOCHET_ADIPOGENESIS	SULT1A2 SULT1A4 SULT1A1 SULT1A3	4.83e-08	24	40	4	MM1317
Coexpression	BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN	LIFR SULT1A2 SULT1A4 SULT1A1 SULT1A3	6.20e-08	68	40	5	MM770
Coexpression	LE_EGR2_TARGETS_DN	SULT1A2 SULT1A4 SULT1A1 SULT1A3 LPL	9.44e-07	117	40	5	MM1139
Coexpression	LANDIS_BREAST_CANCER_PROGRESSION_DN	SULT1A2 SULT1A4 SULT1A1 SULT1A3	5.23e-06	75	40	4	MM1084
Coexpression	THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN	DOCK2 MYOF SULT1A2 SULT1A4 SULT1A1 SULT1A3 FCGRT TM9SF4 FGD3	6.99e-06	905	40	9	M40865
Coexpression	YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7	SULT1A2 SULT1A4 SULT1A1 SULT1A3	8.21e-06	84	40	4	MM873
Coexpression	GSE13485_CTRL_VS_DAY3_YF17D_VACCINE_PBMC_DN	MYOF TRIM69 DDX60 ABCC10 SCARB2	1.27e-05	199	40	5	M3286
Coexpression	GSE12198_LOW_IL2_STIM_NK_CELL_VS_HIGH_IL2_STIM_NK_CELL_DN	DOCK2 STIM1 TTC8 USP11 SEL1L3	1.30e-05	200	40	5	M7066
Coexpression	LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_XDGS_UP	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.22e-05	108	40	4	MM1334
Coexpression	JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP	SULT1A2 SULT1A1 SULT1A3 UPF2 FGD3 ASNS	2.26e-05	380	40	6	M38974
Coexpression	SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_MEDIUM_HIGH_ADVERSE_EVENTS_SCORE_1DY_DN	SULT1A2 SULT1A4	2.26e-05	5	40	2	M41007
Coexpression	FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_1DY_POSITIVE	MYOF DDX60 SCARB2 ZC3HAV1	4.46e-05	129	40	4	M41110
Coexpression	IWANAGA_CARCINOGENESIS_BY_KRAS_DN	SULT1A2 SULT1A4 SULT1A1 SULT1A3	5.33e-05	135	40	4	MM753
Coexpression	GUILLAUMOND_KLF10_TARGETS_UP	CPT1A LPL ASNS	6.14e-05	50	40	3	M2485
Coexpression	TABULA_MURIS_SENIS_LIVER_HEPATOCYTE_AGEING	SULT1A2 SULT1A4 SULT1A1 SULT1A3	7.42e-05	147	40	4	MM3753
Coexpression	RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN	SULT1A2 SULT1A4 SULT1A1 SULT1A3 UPF2	7.55e-05	289	40	5	MM1238
Coexpression	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP	MYOF SULT1A2 SULT1A4 TMC7 SULT1A1 SULT1A3	9.27e-05	490	40	6	MM1001
Coexpression	JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_DN	SULT1A2 SULT1A1 SULT1A3 UPF2 FGD3	9.29e-05	302	40	5	M38975
Coexpression	INGRAM_SHH_TARGETS_UP	SULT1A2 SULT1A4 SULT1A1 SULT1A3	9.34e-05	156	40	4	MM550
Coexpression	LANDIS_ERBB2_BREAST_TUMORS_324_DN	SULT1A2 SULT1A4 SULT1A1 SULT1A3	9.57e-05	157	40	4	MM1099
Coexpression	GUILLAUMOND_KLF10_TARGETS_UP	CPT1A LPL ASNS	1.01e-04	59	40	3	MM952
Coexpression	RODWELL_AGING_KIDNEY_UP	DOCK2 ARHGDIB MYOF OSMR ASNS SEL1L3	1.05e-04	501	40	6	M5389
Coexpression	RODRIGUES_NTN1_TARGETS_DN	MYOF SULT1A2 SULT1A1 SULT1A3	1.05e-04	161	40	4	M11857
Coexpression	GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP	MYOF DDX60 LPL ASNS	1.45e-04	175	40	4	M7625
Coexpression	FLETCHER_PBMC_BCG_10W_INFANT_PPD_STIMULATED_VS_UNSTIMULATED_10W_DN	MYOF FCGRT SCARB2 LPL	1.66e-04	181	40	4	M40912
Coexpression	LEE_BMP2_TARGETS_UP	SULT1A2 SULT1A4 SULT1A1 SULT1A3 FCGRT SCARB2 LPL	1.93e-04	805	40	7	MM1067
Coexpression	NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_UP	MYOF TRIM69 SULT1A1 DDX60 TM9SF4 SCARB2	1.95e-04	562	40	6	M41008
Coexpression	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_18H_DN	TRIM69 USP11 DDX60 ZC3HAV1	2.12e-04	193	40	4	M4284
Coexpression	GSE12366_GC_VS_NAIVE_BCELL_DN	CD72 CHD1 LYST DDX60	2.20e-04	195	40	4	M3170
Coexpression	GSE14000_4H_VS_16H_LPS_DC_TRANSLATED_RNA_UP	DOCK2 ARHGDIB TMC7 ZC3HAV1	2.24e-04	196	40	4	M3351
Coexpression	GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_AND_IL4_STIM_DN	MYOF TRIM69 CPT1A SEL1L3	2.24e-04	196	40	4	M8003
Coexpression	GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_10DY_UP	MYOF DDX60 SCARB2 ZC3HAV1	2.24e-04	196	40	4	M41141
Coexpression	GSE13485_DAY7_VS_DAY21_YF17D_VACCINE_PBMC_UP	MYOF TRIM69 DDX60 SCARB2	2.29e-04	197	40	4	M3307
Coexpression	GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_DN	MYOF TRIM69 DDX60 SCARB2	2.33e-04	198	40	4	M3296
Coexpression	GSE22033_UNTREATED_VS_ROSIGLITAZONE_TREATED_MEF_DN	ELOVL4 CD72 CHD1 ABCC10	2.38e-04	199	40	4	M7690
Coexpression	GSE13485_PRE_VS_POST_YF17D_VACCINATION_PBMC_DN	MYOF TRIM69 DDX60 SCARB2	2.38e-04	199	40	4	M3311
Coexpression	GSE16266_LPS_VS_HEATSHOCK_AND_LPS_STIM_MEF_UP	LRP4 TTC8 CD72 SULT1A1	2.38e-04	199	40	4	M7210
Coexpression	GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_1H_DN	DOCK2 MYOF CPT1A SCARB2	2.38e-04	199	40	4	M9913
Coexpression	GSE369_SOCS3_KO_VS_WT_LIVER_DN	ARHGDIB CPT1A TMC7 FGD3	2.42e-04	200	40	4	M5963
Coexpression	GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_DN	MYOF TRIM69 DDX60 SCARB2	2.42e-04	200	40	4	M3288
Coexpression	GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_UP	DOCK2 CD72 DDX60 ZC3HAV1	2.42e-04	200	40	4	M6625
Coexpression	GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_16H_DN	DOCK2 LYST SCARB2 LPL	2.42e-04	200	40	4	M8267
Coexpression	GSE42021_TREG_PLN_VS_TREG_PRECURSORS_THYMUS_DN	OSMR DDX60 SCARB2 ZC3HAV1	2.42e-04	200	40	4	M9570
Coexpression	GSE29618_BCELL_VS_MONOCYTE_DAY7_FLU_VACCINE_DN	SULT1A2 SULT1A1 FCGRT SCARB2	2.42e-04	200	40	4	M4955
Coexpression	GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_TREG_UP	CD72 UPF2 DDX60 FGD3	2.42e-04	200	40	4	M4313
Coexpression	NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP	CD72 SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.38e-04	399	40	5	M41172
Coexpression	GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_3DY_UP	MYOF DDX60 SCARB2 ZC3HAV1	3.42e-04	219	40	4	M41142
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HENDO	LIFR OSMR CPT1A TMC7 FCGRT ZC3HAV1 SEL1L3	3.51e-04	888	40	7	M39049
Coexpression	YAGI_AML_WITH_INV_16_TRANSLOCATION	CD72 CDR1 CHD1 OSMR TM9SF4	3.87e-04	411	40	5	M1047
Coexpression	KIM_MYCN_AMPLIFICATION_TARGETS_UP	LRP4 CDR1 L3MBTL4	3.88e-04	93	40	3	M18532
Coexpression	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP	ARHGDIB LPL ASNS ZC3HAV1 SEL1L3	4.61e-04	427	40	5	M17923
Coexpression	RIGGI_EWING_SARCOMA_PROGENITOR_UP	ARHGDIB SULT1A2 FCGRT LPL SEL1L3	5.12e-04	437	40	5	M15981
Coexpression	QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_EXPANSION_OF_VZV_SPECIFIC_T_CELLS_TO_PEAK_AT_1DY_POSITIVE	ARHGDIB CHD1 UPF2 FGD3	5.47e-04	248	40	4	M40874
Coexpression	SWEET_LUNG_CANCER_KRAS_DN	LIFR SULT1A2 SULT1A4 SULT1A1 SULT1A3	5.51e-04	444	40	5	MM1051
Coexpression	FLETCHER_PBMC_BCG_10W_INFANT_BCG_STIMULATED_VS_UNSTIMULATED_10W_DN	MYOF FCGRT SCARB2 LPL	6.16e-04	256	40	4	M41152
Coexpression	NAKAYA_MYELOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN	MYOF CDR1 CPT1A DDX60	7.21e-04	267	40	4	M41130
Coexpression	TABULA_MURIS_SENIS_AORTA_FIBROBLAST_OF_CARDIAC_TISSUE_AGEING	SULT1A2 SULT1A4 SULT1A1 SULT1A3 LYST LPL	7.44e-04	723	40	6	MM3672
CoexpressionAtlas	dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_500	STIM1 LRP4 LPL SEL1L3	7.71e-06	69	39	4	gudmap_dev gonad_e11.5_M_GonMes_Sma_k4_500
CoexpressionAtlas	kidney_adult_Mesangium_Meis_top-relative-expression-ranked_500	LIFR ARHGDIB OSMR LYST DDX60 SCARB2 LPL	1.15e-05	429	39	7	gudmap_kidney_adult_Mesangium_Meis_500
CoexpressionAtlas	dev gonad_e11.5_M_SupCellPrec_Sry_top-relative-expression-ranked_200	STIM1 LRP4 LPL ASNS SEL1L3	1.20e-05	164	39	5	gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_200
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000	STIM1 TTC8 LIFR ARHGDIB MYOF USP11 LPL ASNS SEL1L3	1.46e-05	827	39	9	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000
CoexpressionAtlas	dev gonad_e11.5_M_SupCellPrec_Sry_k-means-cluster#4_top-relative-expression-ranked_200	STIM1 LRP4 LPL	5.40e-05	40	39	3	gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_k4_200
CoexpressionAtlas	gudmap_RNAseq_p2_Glomerlular Endothelial_2500_K4	OSMR FCGRT DDX60 SCARB2 LPL ZC3HAV1	7.42e-05	392	39	6	gudmap_RNAseq_p2_Glomerlular Endothelial_2500_K4
CoexpressionAtlas	Mesoderm Day 15_vs_Mesoderm Day 5-Confounder_removed-fold2.0_adjp0.05	STIM1 LRP4 ARHGDIB MYOF SULT1A2 SULT1A4 SULT1A1 SULT1A3 FCGRT	9.38e-05	1049	39	9	PCBC_ratio_MESO-15_vs_MESO-5_cfr-2X-p05
CoexpressionAtlas	dev gonad_e12.5_M_SertoliCell_Sox9_k-means-cluster#4_top-relative-expression-ranked_500	STIM1 LRP4 LPL SEL1L3	1.18e-04	138	39	4	gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_k4_500
CoexpressionAtlas	dev gonad_e11.5_M_SupCellPrec_Sry_top-relative-expression-ranked_500	STIM1 LRP4 LPL ASNS ZC3HAV1 SEL1L3	1.27e-04	432	39	6	gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_500
CoexpressionAtlas	kidney_adult_Mesangium_Meis_top-relative-expression-ranked_1000	LIFR ARHGDIB OSMR FCGRT LYST DDX60 SCARB2 LPL	1.55e-04	872	39	8	gudmap_kidney_adult_Mesangium_Meis_1000
CoexpressionAtlas	dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#1_top-relative-expression-ranked_1000	STIM1 LRP4 LPL SEL1L3	1.89e-04	156	39	4	gudmap_dev gonad_e11.5_M_GonMes_Sma_k1_1000
CoexpressionAtlas	dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#4_top-relative-expression-ranked_1000	STIM1 LPL ZC3HAV1 SEL1L3	2.62e-04	170	39	4	gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k4_1000
CoexpressionAtlas	dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#4_top-relative-expression-ranked_500	STIM1 LPL SEL1L3	3.00e-04	71	39	3	gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k4_500
CoexpressionAtlas	dev gonad_e12.5_M_SertoliCell_Sox9_top-relative-expression-ranked_200	STIM1 LPL ZC3HAV1 SEL1L3	3.06e-04	177	39	4	gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_200
CoexpressionAtlas	Myeloid Cells, MF.Thio5.II+480lo.PC, CD115+ MHC II+ F480lo SiglecF- CD11c+, Peritoneal Cavity, avg-3	LIFR MYOF LPL	3.13e-04	72	39	3	GSM605859_100
CoexpressionAtlas	JC_iEC_top-relative-expression-ranked_1000_k-means-cluster#2	SULT1A2 SULT1A4 SULT1A3 LYST	3.26e-04	180	39	4	JC_iEC_1000_K2
CoexpressionAtlas	gudmap_RNAseq_e15.5_Podocytes_2500_K2	ARHGDIB FCGRT SCARB2 LPL ZC3HAV1	3.42e-04	333	39	5	gudmap_RNAseq_e15.5_Podocytes_2500_K2
CoexpressionAtlas	Myeloid Cells, DC.II+480lo.PC, F4/80lo MHC II+ CD11c+ CD115+, Peritoneal Cavity, avg-3	LIFR MYOF LPL	3.81e-04	77	39	3	GSM854294_100
CoexpressionAtlas	MESO-15 blastocyst_vs_MESO-15 amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05	SULT1A2 SULT1A4 BNIP3 TMC7 SULT1A1 SULT1A3 FCGRT	3.85e-04	751	39	7	PCBC_ratio_MESO-15 blastocyst_vs_MESO-15 amniotic fluid MSC_cfr-2X-p05
CoexpressionAtlas	kidney_adult_RenalCapsule_top-relative-expression-ranked_1000	ARHGDIB MYOF OSMR SULT1A1 FCGRT DDX60 LPL	4.76e-04	778	39	7	gudmap_kidney_adult_RenalCapsule_1000
CoexpressionAtlas	Myeloid Cells, DC.103-11b+.Lv, CD45+ CD11c+ MHC-II + CD11b high CD103-, Liver, avg-3	LIFR MYOF LPL	5.28e-04	86	39	3	GSM538239_100
CoexpressionAtlas	Myeloid Cells, DC.103-11b+.Salm3.SI, CD45+ MHCII+ Gr1- CD11c-hi CD11b+ CD103- F480+, Small Intestine, avg-4	LIFR CD72 MYOF SULT1A1 FCGRT	5.40e-04	368	39	5	GSM854258_500
CoexpressionAtlas	mendel_RNAseq_e18.5_Urothelium_Krt5CreRFP_2500_K4	STIM1 ARHGDIB MYOF BNIP3 CPT1A ABCC10 SCARB2 ASNS ZC3HAV1	5.74e-04	1337	39	9	mendel_RNAseq_e18.5_Urothelium_Krt5CreRFP_2500_K4
CoexpressionAtlas	gudmap_RNAseq_p2_CD2APMEISWT_2500_K4	ARHGDIB MYOF OSMR FCGRT DDX60 SCARB2 LPL	7.62e-04	842	39	7	gudmap_RNAseq_p2_CD2APMEISWT_2500_K4
CoexpressionAtlas	kidney_adult_RenMedVasc_Tie2_top-relative-expression-ranked_1000	LIFR ARHGDIB OSMR SULT1A1 DDX60 SCARB2 ZC3HAV1	8.06e-04	850	39	7	gudmap_kidney_adult_RenMedVasc_Tie2_1000
CoexpressionAtlas	Myeloid Cells, DC.103-11b+24+.Lu, MHCII+ CD11c+ CD103- CD11b+ CD24+, Lung, avg-2	LIFR CD72 MYOF FCGRT LPL	8.22e-04	404	39	5	GSM854269_500
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_1000	STIM1 LPL SEL1L3	9.18e-04	104	39	3	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_1000
CoexpressionAtlas	dev gonad_e12.5_M_SertoliCell_Sox9_k-means-cluster#1_top-relative-expression-ranked_100	STIM1 SEL1L3	9.60e-04	25	39	2	gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_k1_100
CoexpressionAtlas	kidney_adult_RenCorpuscGlomer_top-relative-expression-ranked_1000	LIFR ARHGDIB MYOF OSMR DDX60 LPL ZC3HAV1	9.75e-04	878	39	7	gudmap_kidney_adult_RenCorpuscGlomer_1000
CoexpressionAtlas	kidney_P2_CapMes_Crym_top-relative-expression-ranked_1000	LRP4 FCGRT LYST CHRNA4 TM9SF4 SEL1L3	9.91e-04	636	39	6	gudmap_kidney_P2_CapMes_Crym_1000
CoexpressionAtlas	Myeloid Cells, MF.Thio5.II+480lo.PC, CD115+ MHC II+ F480lo SiglecF- CD11c+, Peritoneal Cavity, avg-3	LIFR MYOF SULT1A1 FCGRT LPL	1.04e-03	426	39	5	GSM605859_500
CoexpressionAtlas	dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_500	STIM1 LRP4 LPL ASNS SEL1L3	1.11e-03	432	39	5	gudmap_dev gonad_e11.5_M_GonMes_Sma_500
CoexpressionAtlas	Myeloid Cells, MF.II-480hi.PC, F4/80hi CD115hi CD11b+ MHC II- CD11c-, Peritoneal Cavity, avg-3	LIFR MYOF SULT1A1 FCGRT LPL	1.18e-03	438	39	5	GSM605850_500
CoexpressionAtlas	Myeloid Cells, MF.Thio5.II-480hi.PC, CD115+ MHC II- F480hi Siglec F-, Peritoneal Cavity, avg-3	MYOF BNIP3 FCGRT LPL SEL1L3	1.22e-03	441	39	5	GSM605862_500
CoexpressionAtlas	dev gonad_e12.5_M_SertoliCell_Sox9_top-relative-expression-ranked_500	STIM1 LRP4 LPL ZC3HAV1 SEL1L3	1.22e-03	441	39	5	gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_500
ToppCell	Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-MAIT\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK2 ARHGDIB FGD3 ZC3HAV1	9.62e-06	149	40	4	f4bee5fdaaa4a1917e403de90e5a62353006df24
ToppCell	facs-Lung-EPCAM-24m-Lymphocytic-Natural_Killer\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK2 CD72 ARHGDIB ZC3HAV1	1.18e-05	157	40	4	071f10d749b590b75a07ab3c7b00956dc7cda4da
ToppCell	facs-Lung-EPCAM-24m-Lymphocytic-NK_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK2 CD72 ARHGDIB ZC3HAV1	1.18e-05	157	40	4	af110085dad5d26b0b7068a78f104ba784fa8564
ToppCell	droplet-Marrow-nan-24m-Lymphocytic-plasma_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD72 MYOF FCGRT LPL	1.47e-05	166	40	4	b3d9b61847c6c96b8cb28b8a6aeda52f43c706ab
ToppCell	LPS-IL1RA+antiTNF-Lymphocytic_B-B_cells-B-cells\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK2 CD72 ARHGDIB SEL1L3	1.54e-05	168	40	4	eeb381b62c7ba263af96de1194ed59e57b6ca3ae
ToppCell	LPS-IL1RA+antiTNF-Lymphocytic_B-B_cells\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK2 CD72 ARHGDIB SEL1L3	1.54e-05	168	40	4	063d0368d656962b335154c230bdcd9236e7c9ad
ToppCell	LPS-IL1RA+antiTNF-Lymphocytic_B\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK2 CD72 ARHGDIB SEL1L3	1.54e-05	168	40	4	a7c4251d8a83bc30196a444028a35c17c24dc291
ToppCell	LPS-IL1RA-Lymphocytic_B-B_cells-B-cells\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK2 CD72 ARHGDIB SEL1L3	1.62e-05	170	40	4	92e0873f618b2fa60c4d555b10f234d5cbcf3325
ToppCell	LPS-IL1RA-Lymphocytic_B-B_cells\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK2 CD72 ARHGDIB SEL1L3	1.62e-05	170	40	4	c181991f933b779f99afc3782f292306f209e2ac
ToppCell	LPS-IL1RA-Lymphocytic_B\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK2 CD72 ARHGDIB SEL1L3	1.62e-05	170	40	4	56284fbfd1e53f67c8c0b7fba64505a4002adba2
ToppCell	LPS-antiTNF-Lymphocytic_B\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK2 CD72 ARHGDIB SEL1L3	1.77e-05	174	40	4	cc493654ea3517bc6a145c7f787f304929636f86
ToppCell	LPS-antiTNF-Lymphocytic_B-B_cells-B-cells\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK2 CD72 ARHGDIB SEL1L3	1.77e-05	174	40	4	9eb3504f9340517ef5d056503044fbdb9ffeb714
ToppCell	LPS-antiTNF-Lymphocytic_B-B_cells\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK2 CD72 ARHGDIB SEL1L3	1.77e-05	174	40	4	b4c2d1c029fcd0d4926aa79a5b789c713919dcf3
ToppCell	LPS-antiTNF-Lymphocytic_NKT-T_cells\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK2 ARHGDIB FGD3 ZC3HAV1	1.85e-05	176	40	4	ea27e18407b8a13e8212830da859efeb8f158690
ToppCell	LPS-antiTNF-Lymphocytic_NKT-T_cells-T-cells\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK2 ARHGDIB FGD3 ZC3HAV1	1.85e-05	176	40	4	bfbab3c5b738b3b0b1540f2059d0245fbd8c0031
ToppCell	LPS-antiTNF-Lymphocytic_NKT\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK2 ARHGDIB FGD3 ZC3HAV1	1.98e-05	179	40	4	ecea75c568911ff56939c9f67ab901497bd4356c
ToppCell	Primary_Visual_cortex_(V1C)-Non-neuronal-Mesenchymal-Mes\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ARHGDIB MYOF CPT1A LPL	2.02e-05	180	40	4	1ade66352570a3f869e21e1055d0a65fbf56c61d
ToppCell	facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ELOVL4 MYOF OSMR SULT1A1	2.02e-05	180	40	4	67c5068b660cd5e727a665cefe3bd5f8ae887221
ToppCell	Primary_Visual_cortex_(V1C)-Non-neuronal-Mesenchymal\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ARHGDIB MYOF CPT1A LPL	2.02e-05	180	40	4	f118c580134bdf3027e2218690cfc8a93468c1ae
ToppCell	RA-17._Lymphocyte\|RA / Chamber and Cluster_Paper	DOCK2 ARHGDIB FGD3 ZC3HAV1	2.11e-05	182	40	4	257a7847917b6ea1d60608183d90300bfd028758
ToppCell	Thalamus-Endothelial\|Thalamus / BrainAtlas - Mouse McCarroll V32	MYOF OSMR FCGRT ZC3HAV1	2.30e-05	186	40	4	dcc6e4417c4123d5ca6b96fa8ca4874626aaebdb
ToppCell	Mesenchymal_cells-Adipo-CAR\|World / Lineage and Cell class	LIFR SULT1A1 FCGRT LPL	2.30e-05	186	40	4	6ca8ce7ced91d6308b7c056032ffec1b37c974bf
ToppCell	Control-T_cells\|Control / group, cell type (main and fine annotations)	DOCK2 ARHGDIB FGD3 ZC3HAV1	2.35e-05	187	40	4	f4e8e0eba58da89b56587667555a5d4754e108c7
ToppCell	LPS_only-Lymphocytic_NKT\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DOCK2 ARHGDIB FGD3 ZC3HAV1	2.40e-05	188	40	4	bbe65b1c11c88ab62d8485cfc3a913ff9da89aad
ToppCell	Substantia_nigra-Endothelial\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	MYOF OSMR SULT1A1 FCGRT	2.45e-05	189	40	4	bef8234bd9c4d6e3cdef0791d8066b39ba56ebba
ToppCell	Control-T_cells-CD4+_T_cells\|Control / group, cell type (main and fine annotations)	DOCK2 ARHGDIB FGD3 ZC3HAV1	2.50e-05	190	40	4	0733be5e54fe15d6d6ea51c154a95258e83f1b92
ToppCell	Fetal_29-31_weeks-Immune-T_lymphocyte-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DOCK2 ARHGDIB FGD3 ZC3HAV1	2.55e-05	191	40	4	133864ec1e89f97a82c3bb01d2a3c658397fefaf
ToppCell	(1)_Control_(PBS)\|World / Stress and Cell class	LIFR SULT1A1 FCGRT LPL	2.55e-05	191	40	4	b346e13259cb2d506b923ad44b894c21a3eee4c3
ToppCell	Fetal_29-31_weeks-Immune-T_lymphocyte-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DOCK2 ARHGDIB FGD3 ZC3HAV1	2.60e-05	192	40	4	92f141d5ac462f652f405efa73ac6ef751f40ea3
ToppCell	Fetal_29-31_weeks-Immune-T_lymphocyte\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DOCK2 ARHGDIB FGD3 ZC3HAV1	2.60e-05	192	40	4	69a2b04f03a1b82d067018379f7b8a116e954040
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-E\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DOCK2 ARHGDIB UPF2 FCGRT	2.60e-05	192	40	4	69758a256386a6ed3a6e2c94c55d59baa34892d7
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-E\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DOCK2 ARHGDIB MYOF FCGRT	2.66e-05	193	40	4	697518bab1338dc441b2d93b410d957e692f20e6
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-E\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DOCK2 ARHGDIB UPF2 FCGRT	2.66e-05	193	40	4	b52d5661edff83ac4c5fe2bf89d6672016bb827b
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DOCK2 ARHGDIB FGD3 SEL1L3	2.71e-05	194	40	4	4dfc890bacf133cfb6ec7c8b73f084f2491cf78e
ToppCell	IPF-Endothelial-VE_Venous\|Endothelial / Disease state, Lineage and Cell class	LIFR MYOF OSMR LYST	2.71e-05	194	40	4	e8a9005963704286bcc50785bda8d7d63ec001b1
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ARHGDIB DDX60 ZC3HAV1 SEL1L3	2.77e-05	195	40	4	662b50a2aa97373bf343b88caace9717049c722a
ToppCell	Cerebellum-Endothelial\|Cerebellum / BrainAtlas - Mouse McCarroll V32	ARHGDIB MYOF SULT1A1 FCGRT	2.77e-05	195	40	4	2192fd9b4682054776f0716933aed5a4a9412657
ToppCell	Posterior_cortex-Endothelial\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	OSMR SULT1A1 FCGRT ZC3HAV1	2.77e-05	195	40	4	988e3449691cc228cb55e5e30355136c97b12262
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-C\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ARHGDIB SULT1A4 SULT1A1 FCGRT	2.82e-05	196	40	4	9ae9cf69079b8a786e775c3db5cd4c593513f698
ToppCell	10x5'v1-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	ELOVL4 LRP4 LIFR OSMR	2.88e-05	197	40	4	2ca5ebb708935a90b12b8e98a22ae2d664ed002e
ToppCell	3'-Child04-06\|3' / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CD72 ARHGDIB SULT1A2 SEL1L3	2.88e-05	197	40	4	5da92d069bb32ede5e8f30c5b68c4d0790373467
ToppCell	PCW_10-12\|World / Celltypes from embryonic and fetal-stage human lung	LIFR MYOF FCGRT LPL	2.88e-05	197	40	4	47fd8b0d596c5db1a722473c8efbb17a6bbe7538
ToppCell	TCGA-Skin-Metastatic-Melanoma\|TCGA-Skin / Sample_Type by Project: Shred V9	DOCK2 LIFR CD72 SEL1L3	2.94e-05	198	40	4	af4fb9eb2295c7b90624b38ba25619aa15254efa
ToppCell	TCGA-Skin-Metastatic\|TCGA-Skin / Sample_Type by Project: Shred V9	DOCK2 LIFR CD72 SEL1L3	2.94e-05	198	40	4	ad39cce004867f083f8da1954e0cf5a263815184
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-non-classical_monocyte\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SULT1A1 FCGRT SCARB2 LPL	2.94e-05	198	40	4	ecf1cb56bdd43b9c62cec3fcf914ede608a7c8a0
ToppCell	10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_macrophage\|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MYOF SULT1A1 FCGRT SCARB2	2.94e-05	198	40	4	9aaff68107ae4542f904b142d23669f2fcd557ac
ToppCell	TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma\|TCGA-Skin / Sample_Type by Project: Shred V9	DOCK2 LIFR CD72 SEL1L3	2.94e-05	198	40	4	62cbf4b29e8af4983fb47a17f96da62682a5137e
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4-T_reg\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK2 ARHGDIB FGD3 ZC3HAV1	2.94e-05	198	40	4	7608f67959e1cda7b10e57fd3af2f96216ebe7e9
ToppCell	10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_macrophage-macrophage\|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MYOF SULT1A1 FCGRT SCARB2	2.94e-05	198	40	4	5aaf3861c53763cf09bb628c9d2eabb6a7277021
ToppCell	Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK2 ARHGDIB FGD3 ZC3HAV1	3.00e-05	199	40	4	bc93e5c36ab60b66fb633c954b05d4dc09a7f152
ToppCell	BAL-Mild-cDC_1\|Mild / Compartment, Disease Groups and Clusters	MYOF DDX60 SCARB2 ZC3HAV1	3.00e-05	199	40	4	c55181bdec8952b54198f0d4c9c5c84265b16572
ToppCell	Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4_naive/CM\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK2 ARHGDIB FGD3 ZC3HAV1	3.00e-05	199	40	4	6150b272313d3fbf5ddcb3a8d51862d368220fe2
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	LIFR MYOF OSMR LPL	3.00e-05	199	40	4	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_TRM\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK2 ARHGDIB FGD3 ZC3HAV1	3.00e-05	199	40	4	b947ecaf912d97869f6df32736b8c2b2dd695d66
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DOCK2 ARHGDIB MYOF FCGRT	3.00e-05	199	40	4	e7faf7d0cb43cf93149c446e5f718f84fa85477c
ToppCell	Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK2 ARHGDIB FGD3 ZC3HAV1	3.00e-05	199	40	4	fbdde57dd88656621801e65ee2818251588f3874
ToppCell	Parenchymal-NucSeq-Immune_Lymphocytic-T\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK2 ARHGDIB FGD3 ZC3HAV1	3.05e-05	200	40	4	dfdfad881c114e1bc9a64b411e1b00fb37cc859b
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	LIFR MYOF OSMR LPL	3.05e-05	200	40	4	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD4\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK2 ARHGDIB FGD3 ZC3HAV1	3.05e-05	200	40	4	d8459e45a8396a9ee063666a1928c649162c5727
ToppCell	Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK2 ARHGDIB FGD3 ZC3HAV1	3.05e-05	200	40	4	5f41906cf1585e09b150a84364d47c3e466dc5b7
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_TRM\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK2 ARHGDIB FGD3 ZC3HAV1	3.05e-05	200	40	4	be9a43acc2f926b9433ab3f018b911b03896a924
ToppCell	Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4_naive/CM\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK2 ARHGDIB FGD3 ZC3HAV1	3.05e-05	200	40	4	cded40d5069a6fdbd90ac9a2a0bbef11727b28d5
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Artery\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	TMC7 LPL ASNS SEL1L3	3.05e-05	200	40	4	77ae679c35d3b9e2b620f34129f3a8d47e922c65
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4_naive/CM\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK2 ARHGDIB FGD3 ZC3HAV1	3.05e-05	200	40	4	e0cec0a844b7c1f8edee4c005af27766754e470a
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-T\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK2 ARHGDIB FGD3 ZC3HAV1	3.05e-05	200	40	4	c6c2b39359c65c9444987d02d1c899dff2ad1366
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK2 ARHGDIB FGD3 ZC3HAV1	3.05e-05	200	40	4	8474e5d031d25bfb8461d39fa2053da01a6304fc
ToppCell	Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK2 ARHGDIB FGD3 ZC3HAV1	3.05e-05	200	40	4	13d8c5d65d7f900979319433e7044efa6d06de20
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK2 ARHGDIB FGD3 ZC3HAV1	3.05e-05	200	40	4	02c4169a23e5aaa0d4bfc78b51ba19ce8157dc3e
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD4\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK2 ARHGDIB FGD3 ZC3HAV1	3.05e-05	200	40	4	9de4d6ebb7e9bee5d811519eb05913ef30f70786
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	LIFR MYOF OSMR LPL	3.05e-05	200	40	4	a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCell	Tracheal-NucSeq-Immune_Lymphocytic-T\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK2 ARHGDIB FGD3 ZC3HAV1	3.05e-05	200	40	4	dbbc7e16929e744b48017da068479a6046e99cf6
ToppCell	Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD4\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK2 ARHGDIB FGD3 ZC3HAV1	3.05e-05	200	40	4	f7a9d8b99de19e9842422bada348d940e0863645
ToppCell	mLN-Dendritic_cell-pDC\|Dendritic_cell / Region, Cell class and subclass	STIM1 SCARB2 ZC3HAV1 SEL1L3	3.05e-05	200	40	4	10ae1ac8a98346320a92e855aebb3a7109f0ab9b
ToppCell	facs-Skin-Anagen-24m-Epithelial-nan\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ELOVL4 LRP4 ARHGDIB	2.62e-04	139	40	3	da8874d441b8e69c94bad771635f378ddafb49fe
ToppCell	P03-Hematopoietic\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	DOCK2 CD72 ARHGDIB	2.73e-04	141	40	3	4a856521520ea73291f4730fe94c5de88c2b6f0c
ToppCell	E18.5-Immune-Immune_Myeloid-Granulocytic-Neutrophil\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DOCK2 ARHGDIB FGD3	2.97e-04	145	40	3	88e463d5396a8fea2b7b1ecf3c9b144e16b35234
ToppCell	E18.5-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DOCK2 ARHGDIB FGD3	2.97e-04	145	40	3	911fee7f27694393e348d94470a1a4e890038902
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Calb1_Sst\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MYOF LPL FGD3	3.03e-04	146	40	3	10839a4fce2e62955a90592f927a6e0c6a84bbad
ToppCell	P15-Hematopoietic\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	DOCK2 CD72 ARHGDIB	3.03e-04	146	40	3	2b3e6ff6069573ee213000aeab5de9a33afc1a99
ToppCell	P03-Hematopoietic-Immune-immune_cell_unspecified\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	DOCK2 CD72 ARHGDIB	3.21e-04	149	40	3	43d756f81d532b5c7f2306e6af9d072d496cbc8e
ToppCell	P03-Hematopoietic-Immune\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	DOCK2 CD72 ARHGDIB	3.21e-04	149	40	3	1c5a2572741c47246d455c865e8e1677c9f49598
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MYOF FCGRT LPL	3.21e-04	149	40	3	c773c2b9685ec44a35246180a93456c8765353f5
ToppCell	P15-Hematopoietic-Immune\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	DOCK2 CD72 ARHGDIB	3.34e-04	151	40	3	a54045cac65a66197e3ad2b002fa6c511102834a
ToppCell	P15-Hematopoietic-Immune-immune_cell_unspecified\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	DOCK2 CD72 ARHGDIB	3.34e-04	151	40	3	6b905d309f2a9b8828399b36f4942aec8696bee6
ToppCell	saliva-Mild-Moderate_progression_d12-25-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	DOCK2 FCGRT DDX60	3.41e-04	152	40	3	18194f757d319958f26e5a91f56d89f25711236f
ToppCell	RV-17._Lymphocyte\|RV / Chamber and Cluster_Paper	DOCK2 FGD3 SEL1L3	3.47e-04	153	40	3	e1ea621184014415870e00d511386b8cc3e0833b
ToppCell	E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CD72 ARHGDIB FCGRT	3.54e-04	154	40	3	79ebda35dd1719e157738d7c13e5b8ccc3991f03
ToppCell	P28-Hematopoietic\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	DOCK2 CD72 ARHGDIB	3.54e-04	154	40	3	13980ae1957b05350c11171c9c118decfe998d3d
ToppCell	E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	LIFR SULT1A2 SCARB2	3.54e-04	154	40	3	e65e4636646164610f33f7bbac0d879a3ea55986
ToppCell	facs-Skin-Anagen-24m-Epithelial-basal_cell_of_epidermis\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LRP4 ARHGDIB BNIP3	3.54e-04	154	40	3	89a94a36dfd3d75e411038f04adaf0bbab17db45
ToppCell	RV-17._Lymphocyte\|World / Chamber and Cluster_Paper	DOCK2 FGD3 SEL1L3	3.61e-04	155	40	3	189276a3b400b2202e6681e23732e6452bfe704e
ToppCell	PND07-28-samps-Myeloid-Granulocyte-neutrophil__Lgals3-negative\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	DOCK2 ARHGDIB LYST	3.68e-04	156	40	3	166f7b1220eaf8e1149dde260dd85a094855c54f
ToppCell	PND07-28-samps-Myeloid-Granulocyte\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	DOCK2 ARHGDIB LYST	3.68e-04	156	40	3	5e1c5a7c9293b886920739cf766521df7f69726c
ToppCell	PBMC-Control-cDC_1\|Control / Compartment, Disease Groups and Clusters	DDX60 VSTM2L ZC3HAV1	3.68e-04	156	40	3	9b6c5bcac516a62bcc1f5be32ffa8c92735ef0bc
ToppCell	facs-Brain_Myeloid-Cerebellum\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD72 CDR1 LPL	3.68e-04	156	40	3	28c4fb4d2c6c47696c3a6722998f9da5a8923323
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Radial_glial-gliogenic/outer_RGCs_and_astrocytes\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	DDX60 PALB2 LPL	3.75e-04	157	40	3	2c1219ee19a6246a3b9f5c2c1a37f26ea934a822
ToppCell	facs-Lung-24m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-natural_killer\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CD72 ARHGDIB ZC3HAV1	3.75e-04	157	40	3	34eb1cbdb023d3e23b2e1695c9c327c21ef1c870
ToppCell	P28-Hematopoietic-Immune-immune_cell_unspecified\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	DOCK2 CD72 ARHGDIB	3.75e-04	157	40	3	a70f93aff07b6b7a9efce33b12b024116648dc0a
ToppCell	P28-Hematopoietic-Immune\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	DOCK2 CD72 ARHGDIB	3.75e-04	157	40	3	b1f520b1e0ea7abb19d0dd27021eafbea0fd90cd
ToppCell	facs-Lung-24m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CD72 ARHGDIB ZC3HAV1	3.75e-04	157	40	3	fc0c222124f59c94d60335f849554eaa4062f8c7
Computational	Neighborhood of TYK2	DOCK2 ARHGDIB CHD1	8.20e-05	33	28	3	GNF2_TYK2
Drug	dopamine-4-O-sulfate	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.85e-10	7	40	4	CID000123932
Drug	2-naphthylsulfate	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.85e-10	7	40	4	CID000074428
Drug	2-iodo-4-azidophenol	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.85e-10	7	40	4	CID003035977
Drug	luciferyl sulfate	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.85e-10	7	40	4	CID011953812
Drug	2-iodophenol	SULT1A2 SULT1A4 SULT1A1 SULT1A3	5.69e-10	8	40	4	CID000010784
Drug	dopamine 3-O-sulfate	SULT1A2 SULT1A4 SULT1A1 SULT1A3	5.69e-10	8	40	4	CID000122136
Drug	6-anilino-2-thiouracil	SULT1A2 SULT1A4 SULT1A1 SULT1A3	5.69e-10	8	40	4	CID003037707
Drug	EM-139	SULT1A2 SULT1A4 SULT1A1 SULT1A3	5.77e-09	13	40	4	CID000131427
Drug	naphthalenemethanol	SULT1A2 SULT1A4 SULT1A1 SULT1A3	8.07e-09	14	40	4	CID000020908
Drug	deoxoestrone	SULT1A2 SULT1A4 SULT1A1 SULT1A3	8.07e-09	14	40	4	CID000005888
Drug	arylsulfate	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.10e-08	15	40	4	CID000074426
Drug	cyclobenzaprine	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.10e-08	15	40	4	CID000002895
Drug	A-44	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.46e-08	16	40	4	CID000120353
Drug	benzilic acid	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.91e-08	17	40	4	CID000006463
Drug	AC1Q6OHG	SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.11e-08	19	40	4	CID000115063
Drug	pedunculagin	SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.11e-08	19	40	4	CID000442688
Drug	PLP-Glu	SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.88e-08	20	40	4	CID000444293
Drug	N-hydroxy-2-aminofluorene	SULT1A2 SULT1A4 SULT1A1 SULT1A3	4.78e-08	21	40	4	CID000005895
Drug	MeA alpha C	SULT1A2 SULT1A4 SULT1A1 SULT1A3	5.84e-08	22	40	4	CID000062244
Drug	AABSSN	SULT1A2 SULT1A4 SULT1A1 SULT1A3	5.84e-08	22	40	4	CID005464134
Drug	taselin	SULT1A2 SULT1A4 SULT1A1 SULT1A3	7.06e-08	23	40	4	CID000023846
Drug	AalphaC	SULT1A2 SULT1A4 SULT1A1 SULT1A3	8.46e-08	24	40	4	CID000062805
Drug	AzMC	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.01e-07	25	40	4	CID000064986
Drug	minoxidil sulphate	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.01e-07	25	40	4	CID000004202
Drug	2-pentanone	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.01e-07	25	40	4	CID000007895
Drug	alpha-methyldopamine	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.19e-07	26	40	4	CID000017005
Drug	glycolithocholic acid	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.19e-07	26	40	4	CID000115245
Drug	1m2q	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.19e-07	26	40	4	CID005326637
Drug	Phosphoadenosine Phosphosulfate	SULT1A2 SULT1A1 SULT1A3	1.75e-07	7	40	3	ctd:D010724
Drug	Glu-P-2	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.88e-07	29	40	4	CID000049970
Drug	3,3'-T2	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.17e-07	30	40	4	CID000065559
Drug	A2'p5'A2'p5'A	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.48e-07	31	40	4	CID000122642
Drug	acetaminophen sulfate	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.48e-07	31	40	4	CID000083939
Drug	barium hydroxide	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.48e-07	31	40	4	CID000028387
Drug	N-hydroxy-4-aminobiphenyl	SULT1A2 SULT1A1 SULT1A3	2.80e-07	8	40	3	ctd:C014593
Drug	DCNP	SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.22e-07	33	40	4	CID000012066
Drug	mefenamic acid	SULT1A2 SULT1A4 SULT1A1 SULT1A3	5.17e-07	37	40	4	CID000004044
Drug	phenylhydroxylamine	SULT1A2 SULT1A4 SULT1A1 SULT1A3	5.77e-07	38	40	4	CID000007518
Drug	d-equilenin	SULT1A2 SULT1A4 SULT1A1 SULT1A3	7.89e-07	41	40	4	CID000010597
Drug	4-octylphenol	SULT1A1 SULT1A3 CHRNA4 CHRNB2	7.89e-07	41	40	4	ctd:C080417
Drug	L-alpha-methyldopa	SULT1A2 SULT1A4 SULT1A1 SULT1A3	8.71e-07	42	40	4	CID000004138
Drug	Woodward's reagent K	SULT1A2 SULT1A4 SULT1A1 SULT1A3	9.59e-07	43	40	4	CID000077804
Drug	NSC674039	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.05e-06	44	40	4	CID000001249
Drug	1IIg	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.15e-06	45	40	4	CID000001682
Drug	NDPS	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.15e-06	45	40	4	CID000090363
Drug	4-octylphenol	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.38e-06	47	40	4	CID000015730
Drug	17alpha-estradiol	LRP4 LIFR CDR1 SULT1A2 SULT1A4 SULT1A1 SULT1A3 CYP11B1 CHRNA4 CHRNB2 SCARB2 LPL	1.47e-06	1303	40	12	CID000000450
Drug	salicylamide	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.50e-06	48	40	4	CID000005147
Drug	sulfamethazine	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.50e-06	48	40	4	CID000005327
Drug	N-hydroxy-2-acetylaminofluorene	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.50e-06	48	40	4	CID000005896
Drug	phenylglyoxal	SULT1A2 SULT1A4 SULT1A1 SULT1A3 FCGRT	2.21e-06	121	40	5	CID000014090
Drug	9-hydroxybenzo(a)pyrene	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.25e-06	53	40	4	CID000028598
Drug	androstenediol	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.42e-06	54	40	4	CID000010634
Drug	minoxidil	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.42e-06	54	40	4	CID000004201
Drug	MeIQx	SULT1A2 SULT1A4 SULT1A1 SULT1A3	2.61e-06	55	40	4	CID000062275
Drug	5-hydroxymethylfurfural	SULT1A2 SULT1A1	3.01e-06	2	40	2	ctd:C008046
Drug	subecholine	CHRNA4 CHRNB2	3.01e-06	2	40	2	ctd:C009335
Drug	Hydroxytryptophol	SULT1A1 SULT1A3	3.01e-06	2	40	2	ctd:D006917
Drug	3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole	CHRNA4 CHRNB2	3.01e-06	2	40	2	ctd:C088383
Drug	ispronicline	CHRNA4 CHRNB2	3.01e-06	2	40	2	ctd:C490152
Drug	5-(2-azetidinylmethoxy)-2-chloropyridine	CHRNA4 CHRNB2	3.01e-06	2	40	2	ctd:C109763
Drug	6-hydroxymelatonin	SULT1A1 SULT1A3	3.01e-06	2	40	2	ctd:C012365
Drug	metanicotine	CHRNA4 CHRNB2	3.01e-06	2	40	2	ctd:C012419
Drug	3-(2-(pyrrolidinyl)methoxy)pyridine	CHRNA4 CHRNB2	3.01e-06	2	40	2	ctd:C116733
Drug	Bridged Bicyclo Compounds, Heterocyclic	CHRNA4 CHRNB2	3.01e-06	2	40	2	ctd:D019086
Drug	TC 2559	CHRNA4 CHRNB2	3.01e-06	2	40	2	ctd:C419442
Drug	Fire Trol 934	CHRNA4 CHRNB2	3.01e-06	2	40	2	ctd:C508049
Drug	NSC36919	SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.24e-06	58	40	4	CID000235496
Drug	4-hydroxyestrone	SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.47e-06	59	40	4	CID000018418
Drug	acetaminophen glucuronide	SULT1A2 SULT1A4 SULT1A1 SULT1A3	3.47e-06	59	40	4	CID000083944
Drug	Dopamine	BNIP3 CPT1A SULT1A1 SULT1A3 CHRNA4 CHRNB2	3.66e-06	240	40	6	ctd:D004298
Drug	3-OHBaP	SULT1A2 SULT1A4 SULT1A1 SULT1A3	4.51e-06	63	40	4	CID000025890
Drug	4-nonylphenol	SULT1A2 SULT1A4 SULT1A1 SULT1A3	4.81e-06	64	40	4	CID000001752
Drug	aniline	SULT1A2 SULT1A4 SULT1A1 SULT1A3 FCGRT	4.85e-06	142	40	5	CID000006115
Drug	epicatechin-3-gallate	SULT1A2 SULT1A4 SULT1A1 SULT1A3	5.12e-06	65	40	4	CID000065056
Drug	Pyrethroids	SULT1A2 SULT1A4 SULT1A1 SULT1A3	7.29e-06	71	40	4	CID000005053
Drug	adenylylsulfate	SULT1A2 SULT1A4 SULT1A1 SULT1A3	7.71e-06	72	40	4	CID000000228
Drug	5-hydroxy-3-methylindole	SULT1A2 SULT1A1	9.02e-06	3	40	2	CID000192734
Drug	ponceau 4R	CHRNA4 CHRNB2	9.02e-06	3	40	2	ctd:C576297
Drug	13,19-didesmethyl spirolide C	CHRNA4 CHRNB2	9.02e-06	3	40	2	ctd:C544516
Drug	sazetidine-A	CHRNA4 CHRNB2	9.02e-06	3	40	2	ctd:C514816
Drug	Alcuronium	CHRNA4 CHRNB2	9.02e-06	3	40	2	ctd:D000443
Drug	A 85380	CHRNA4 CHRNB2	9.02e-06	3	40	2	ctd:C104288
Drug	5-hydroxyindole	SULT1A1 SULT1A3	9.02e-06	3	40	2	ctd:C026785
Drug	Minoxidil	SULT1A1 SULT1A3	9.02e-06	3	40	2	ctd:D008914
Drug	13-desmethylspirolide C	CHRNA4 CHRNB2	9.02e-06	3	40	2	ctd:C517170
Drug	desformylflustrabromine	CHRNA4 CHRNB2	9.02e-06	3	40	2	ctd:C524215
Drug	8-azaadenine	SULT1A1 SULT1A3	9.02e-06	3	40	2	ctd:C006654
Drug	brilliant blue	CHRNA4 CHRNB2	9.02e-06	3	40	2	ctd:C006796
Drug	3,3'-diiodothyronine	SULT1A1 SULT1A3	9.02e-06	3	40	2	ctd:C030629
Drug	7-hydroxycoumarin	SULT1A2 SULT1A4 SULT1A1 SULT1A3	9.07e-06	75	40	4	CID005281426
Drug	benzyloxyresorufin	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.06e-05	78	40	4	CID000114982
Drug	4-hydroxyestradiol	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.12e-05	79	40	4	CID000001743
Drug	epicholesterol	LRP4 CPT1A LYST CYP11B1 CHRNA4 CHRNB2 SCARB2 LPL	1.24e-05	636	40	8	CID000000304
Drug	3,4,3',4'-tetrachlorobiphenyl	BNIP3 CPT1A TMC7 FCGRT CYP11B1 SCARB2 ASNS	1.25e-05	453	40	7	ctd:C028451
Drug	reverse T3	SULT1A2 SULT1A4 SULT1A1 SULT1A3	1.29e-05	82	40	4	CID000022069
Drug	benzyl alcohol	CDR1 SULT1A2 CPT1A SULT1A1	1.36e-05	83	40	4	CID000000244
Drug	4-nonylphenol	SULT1A1 SULT1A3 CHRNA4 CHRNB2 LPL	1.54e-05	180	40	5	ctd:C041594
Drug	beta-erythroidine	CHRNA4 CHRNB2	1.80e-05	4	40	2	ctd:C004873
Drug	Anabasine	CHRNA4 CHRNB2	1.80e-05	4	40	2	ctd:D000691
Disease	Frontal Epilepsy, Benign, Childhood	CHRNA4 CHRNB2	9.17e-06	4	37	2	C0393671
Disease	Epilepsy, Cingulate	CHRNA4 CHRNB2	9.17e-06	4	37	2	C0393684
Disease	Epilepsy, Supplementary Motor	CHRNA4 CHRNB2	9.17e-06	4	37	2	C0393683
Disease	Epilepsy, Opercular	CHRNA4 CHRNB2	9.17e-06	4	37	2	C0393688
Disease	Epilepsy, Orbito-Frontal	CHRNA4 CHRNB2	9.17e-06	4	37	2	C0751643
Disease	Epilepsy, Anterior Fronto-Polar	CHRNA4 CHRNB2	9.17e-06	4	37	2	C0751642
Disease	Epilepsy, Frontal Lobe	CHRNA4 CHRNB2	9.17e-06	4	37	2	C0085541
Disease	Autosomal dominant nocturnal frontal lobe epilepsy	CHRNA4 CHRNB2	9.17e-06	4	37	2	cv:C3696898
Disease	Sleep Disorders	CHRNA4 CHRNB2	3.20e-05	7	37	2	C0851578
Disease	limb-girdle muscular dystrophy (implicated_via_orthology)	MYOF FER1L5	3.20e-05	7	37	2	DOID:11724 (implicated_via_orthology)
Disease	Autosomal Dominant Nocturnal Frontal Lobe Epilepsy	CHRNA4 CHRNB2	3.20e-05	7	37	2	C3696898
Disease	Subwakefullness Syndrome	CHRNA4 CHRNB2	3.20e-05	7	37	2	C0751511
Disease	Sleep-Related Neurogenic Tachypnea	CHRNA4 CHRNB2	3.20e-05	7	37	2	C0751510
Disease	Short Sleeper Syndrome	CHRNA4 CHRNB2	3.20e-05	7	37	2	C0751509
Disease	Long Sleeper Syndrome	CHRNA4 CHRNB2	3.20e-05	7	37	2	C0751508
Disease	Sleep Wake Disorders	CHRNA4 CHRNB2	3.20e-05	7	37	2	C4042891
Disease	X-12707 measurement	SULT1A2 SULT1A1	1.00e-04	12	37	2	EFO_0800720
Disease	Prostatic Neoplasms	LIFR CHD1 BNIP3 SULT1A1 PALB2 LPL	1.08e-04	616	37	6	C0033578
Disease	Malignant neoplasm of prostate	LIFR CHD1 BNIP3 SULT1A1 PALB2 LPL	1.08e-04	616	37	6	C0376358
Disease	Depressed mood	TRIM69 CHRNA4	1.18e-04	13	37	2	C0344315
Disease	ascorbic acid 3-sulfate measurement	SULT1A2 SULT1A1	1.38e-04	14	37	2	EFO_0800173
Disease	Autosome Abnormalities	SULT1A2 SULT1A1	1.82e-04	16	37	2	C0004403
Disease	Chromosome Aberrations	SULT1A2 SULT1A1	1.82e-04	16	37	2	C0008625
Disease	congenital myasthenic syndrome (implicated_via_orthology)	CHRNA4 CHRNB2	1.82e-04	16	37	2	DOID:3635 (implicated_via_orthology)
Disease	docosahexaenoic acid to total fatty acids percentage	CPT1A LPL	3.16e-04	21	37	2	EFO_0022262
Disease	Attention Deficit Disorder	CHRNA4 CHRNB2	3.48e-04	22	37	2	C0041671
Disease	Minimal Brain Dysfunction	CHRNA4 CHRNB2	3.48e-04	22	37	2	C1321905
Disease	Attention deficit hyperactivity disorder	CHRNA4 CHRNB2	4.15e-04	24	37	2	C1263846
Disease	triglycerides:total lipids ratio, intermediate density lipoprotein measurement	LRP4 CPT1A LPL	5.44e-04	127	37	3	EFO_0008595, EFO_0020947
Disease	obesity (biomarker_via_orthology)	BNIP3 CPT1A LPL	8.31e-04	147	37	3	DOID:9970 (biomarker_via_orthology)
Disease	triacylglycerol 56:8 measurement	CPT1A LPL	9.38e-04	36	37	2	EFO_0010435
Disease	calcium measurement	STIM1 CPT1A FER1L5 FCGRT ABCC10	1.07e-03	628	37	5	EFO_0004838
Disease	degree of unsaturation measurement	CPT1A LPL	1.10e-03	39	37	2	EFO_0022261
Disease	docosahexaenoic acid measurement, fatty acid measurement	CPT1A LPL	1.16e-03	40	37	2	EFO_0005110, EFO_0007761

Protein segments in the cluster

Peptide	Gene	Start	Entry
DWLSHYWMPKWINAT	ASNS	531	P08243
NVWVKQEWHDYKLRW	CHRNA4	86	P43681
LKLKSWWATNYVSDW	CPT1A	221	P50416
QSSKCNKVHKTWSWW	CD72	321	P21854
NKVHKTWSWWTLESE	CD72	326	P21854
KWKGWSHIHNTWETE	CHD1	321	O14646
FFWKTLTDWKTWISF	CDR1	226	P51861
STTVKWNQVLHWSWE	OSMR	86	Q99650
AADWWLSHWISQLKA	ABCC10	901	Q5T3U5
YRWTWSIADKRVENW	ELOVL4	26	Q9GZR5
HLTEWLQSVKWYWKQ	DDX60	926	Q8IY21
WENQVSWYWEKETTD	FCGRT	76	P55899
KLKWKSDSYFSWSDW	LPL	406	P06858
AWSWEWYLKEQKAVA	L3MBTL4	51	Q8NA19
VWKLQWAKQSWYLSA	FGD3	671	Q5JSP0
SLWKALDAWQWEKLY	PALB2	896	Q86YC2
VESILKKNSDWIWDW	BNIP3	106	Q12983
WEWGSIWKQLYVASK	DOCK2	96	Q92608
HLSWEWNLSIKKEWT	ARHGDIB	186	P52566
RWTSPKVWKEHFEAW	CYP11B1	246	P15538
SWTYEEIKEVHKRWW	LYST	3066	Q99698
CSTETFWKWSKWSNK	LIFR	511	P42702
RYVWWKKSLEVWTKD	UPF2	951	Q9HAU5
WITHKYSGRDWNVKW	SEL1L3	176	Q68CR1
DWWSKLFWATDEHKS	FER1L5	1386	A0AVI2
TKIVEWNGKTSLDWW	SCARB2	226	Q14108
WKAWKSSEVYNWTVD	STIM1	121	Q13586
SWYQHVQEWWELSRT	SULT1A4	171	P0DMN0
SWYQHVQEWWELSRT	SULT1A3	171	P0DMM9
VWLTQEWEDYRLTWK	CHRNB2	81	P17787
GKWYWEVEVAKKTKW	TRIM69	376	Q86WT6
WKDTSRATLWKWEGV	nan	261	Q6ZTK2
LSTEHSQYKDWWWKV	TTC8	241	Q8TAM2
WEESDIKWASRWDTY	TM9SF4	256	Q92544
SWYQHVQEWWELSRT	SULT1A1	171	P50225
SWYQHVQEWWELSRT	SULT1A2	171	P50226
SVFTTKWIWYWKNES	ZC3HAV1	601	Q7Z2W4
KWIWYWKNESGTWIQ	ZC3HAV1	606	Q7Z2W4
IQWWYVRSHRDWTDK	VSTM2L	76	Q96N03
SWFLVEKHWYKQWEA	USP11	101	P51784
EWDQWKRYSSKSWKR	TMC7	116	Q7Z402
DRWIYWTDWQTKSIQ	LRP4	1566	O75096
WEYASLIGWKFHWKQ	MYOF	1051	Q9NZM1